Experimental and Computational Characterizations of Native Ligaments, Tendons, and Engineered 3-D Bone-Ligament-Bone Constructs in the Knee. by Ma, Jinjin
Experimental and Computational Characterizations of Native 
Ligaments, Tendons, and Engineered 3-D Bone-Ligament-Bone 








A dissertation submitted in partial fulfillment 
Of the requirements for the degree of 
Doctor of Philosophy 
(Mechanical Engineering) 














Professor Ellen M. Arruda, Co-Chair 
Associate Professor Lisa M. Larkin, Co-Chair 
Professor James A. Ashton-Miller 




















© Jinjin Ma 2012 













































I would like to deeply thank my advisors Prof. Ellen M. Arruda and Prof. 
Lisa M. Larkin for their tremendous guidance, encouragement, support, and trust 
in me during the past five years. I am grateful to Ellen and Lisa for their 
knowledge and research skills. I am always encouraged and inspired by their 
passion towards research. I appreciate their brilliant ideas that they provided to 
me and their accessibility whenever I needed help and guidance. Especially I 
would like to thank Ellen for her willingness to have long discussions during our 
weekly or sometimes daily meetings. I would also like to thank Ellen for kindly 
supporting me to many conferences during the past five years. Through the 
conference opportunities, I have truly grown a lot professionally. Both Ellen and 
Lisa patiently guided me throughout the entire doctoral process, pushing me to 
achieve nothing but the best.  
 
Next, I would like to thank Dr. Edward Wojtys for his guidance, 
encouragement, support, and kindness. I am very grateful to Dr. Wojtys for being 
extremely patient during the ACL surgery when I didn’t know anything. I am also 
grateful for the time and energy he put on the ACL project. I appreciate all the 
beautiful histology work Prof. Tatiana Kostrominova provided for this project. I 
also appreciate the PCR work Prof. Deneen Wellik and her student Ilea 
Swinehart provided for this project. I would also like to thank my committee 
members, Prof. James Ashton-Miller and Prof. Scott Mclean for their suggestions 
and participations on my committee. I also appreciate Prof. Samantha Daly for 
her valuable advice on DIC Methods, and Prof. Krishna Garikipati for his valuable 
advice on finite element modeling. I would also like to thank Dr. Elizabeth 




Next, I would like to thank my teammates, Mike Smietana and Hiroko 
Nakahama, who also have worked so hard on my projects. Thank you for always 
being there no matter how late the experiments went. Thank you for your 
flexibilities so that you were always available to help me whenever I needed help. 
I would not have accomplished the project without your help and support. I am 
also grateful to all STEL members and members in GGB 1025 and 3121, past 
and present, for your great support. I really enjoyed working with you guys. In 
particular, I am grateful to Sarah and Fatima for their guidance and great support 
during the initial stage of my projects. I would also like to thank Charlie, Kelly and 
Phil for their assistance.   
 
Next, I would like to thank my friends in Ann Arbor, friends in graduate 
school and friends in Harvest Mission Community Church: Yipei, Astin, Aftin, Yu, 
Jess, Harish, Keqin, Siying, Rachel, Sarah, Shelly, Mirae, Kathleen, and many 
others. I appreciate so much for your love and support. I cherish our friendships 
so much and hope they shall always last.     
 
Lastly, I would like to give my deepest appreciation to my parents and my 
husband Yi Liu. Without your trust, support, patience, and love, I could not 
overcome the hardships and difficulties I encountered during the past five years. I 
would like to thank my parents for constantly calling me to support and 
encourage me no matter how busy they are and where they are. I would like to 
thank Yi for cooking for months when I am busy. Thank you for your willingness 
to always work around my schedule. Thank you for always forgiving me when I 
lost control or my temper. Thank you for being such a perfect husband. To all of 
you, I dedicate this dissertation.    
 
This work was financially supported by the Department of Mechanical 
Engineering, MICHR, Coulter Foundation, Rackham travel grant and Rackham 
graduate student research grant.  
 v 
Table of Contents 
Dedication ................................................................................................. ii	  
Acknowledgements ................................................................................. iii	  
List of Figures ........................................................................................... x	  
Lists of Tables ......................................................................................... xx	  
Chapter 1	  
Introduction ............................................................................................... 1	  
1.1	   Anterior cruciate ligament (ACL) and its tendon grafts ................... 1	  
1.2	   Characterization of ligaments and tendons .................................... 3	  
1.2.1	   Experimental characterization .................................................. 3	  
1.2.2	   Constitutive models .................................................................. 4	  
1.2.3	   Finite element models .............................................................. 4	  
1.3	   Aim and outline of this thesis .......................................................... 4	  
1.4	   References ...................................................................................... 6	  
Chapter 2	  
Background and Motivation .................................................................... 9	  
2.1	   ACL Anatomy and Function ............................................................ 9	  
2.1.1	   Macroscopic anatomy of the ACL ........................................... 10	  
2.1.2	   Micro anatomy of the ACL ...................................................... 13	  
2.1.3	   Vascularization and innervation .............................................. 17	  
2.1.4	   ACL function ........................................................................... 18	  
2.1.5	   The biomechanical properties of the ACL .............................. 20	  
2.2	   ACL Injuries .................................................................................. 21	  
2.2.1	   Diagnosis and ACL tear patterns ............................................ 22	  
2.2.2	   ACL tear mechanisms ............................................................ 23	  
 vi 
2.3	   ACL repair and its outcomes ......................................................... 24	  
2.3.1	   Healing of the ligament ........................................................... 24	  
2.3.2	   Current surgical strategies ...................................................... 27	  
2.3.3	   Outcomes of the current ACL reconstruction ......................... 27	  
2.4	   Summary ....................................................................................... 29	  
2.5	   References .................................................................................... 30	  
Chapter 3	  
Scaffold-Less Tissue Engineered Bone-Ligament-Bone Constructs 39	  
3.1	   Current trends in tissue engineering ............................................. 40	  
3.1.1	   Scaffold ................................................................................... 40	  
3.1.2	   Cells ........................................................................................ 44	  
3.1.3	   Growth factors ........................................................................ 46	  
3.1.4	   Morphological characterization methods of tissue engineered 
ligaments ............................................................................... 46	  
3.1.5	   Remarks ................................................................................. 47	  
3.2	   Creation of a bone-ligament-bone (BLB) construct and its use as a 
medial collateral ligament (MCL) replacement ............................. 47	  
3.2.1	   In vitro co-culture of BLB constructs ....................................... 48	  
3.2.2	   In vivo BLB construct implantation as an MCL replacement in 
rat ........................................................................................... 51	  
3.2.3	   Morphological analysis of the BLB in vitro, BLB explant, and 
native MCLs ........................................................................... 53	  
3.2.4	   Summary of engineered BLBs used as MCL replacements ... 58	  
3.3	   BLB constructs used as ACL grafts in sheep model ..................... 59	  
3.3.1	   In vitro co-culture of the bone-ligament-bone (BLB) construct 59	  
3.3.2	   In vivo sheep BLB construct used as ACL replacement ......... 62	  
3.3.3	   Growth of BLB constructs and PT autografts during ACL 
replacement ........................................................................... 65	  
3.3.4	   Morphological characterization of the sheep BLB in vitro, BLB 
explant, PT autograft, native ACL and PT ............................. 66	  
3.3.5	   Y chromosome PCR analysis for BLB explant ....................... 74	  
 vii 
3.3.6	   Summary ................................................................................ 75	  
3.4	   Conclusions .................................................................................. 76	  
3.5	   References .................................................................................... 76	  
Chapter 4	  
Biomechanical Characterization of Native and Engineered Ligaments
 .................................................................................................................. 83	  
4.1	   Current Understanding of the Biomechanics of Soft Tissue ......... 83	  
4.1.1	   Biomechanical characterization of the human ACL ................ 85	  
4.1.2	   Human tendon graft (patellar tendon) mechanical 
characterization ..................................................................... 89	  
4.1.3	   Summary of current human tissue mechanics testing ............ 92	  
4.1.4	   Animal models for tissue biomechanics characterization ....... 95	  
4.2	   The viscoelastic properties of ligaments and tendons .................. 96	  
4.2.1	   Strain rate dependence of ligaments and tendons ................. 97	  
4.2.2	   Stress relaxation and creep of ligaments and tendons ........... 97	  
4.3	   Experimental Analysis of Native and Engineered Rat MCLs ........ 98	  
4.3.1	   Cyclic uniaxial tensile tests ..................................................... 99	  
4.3.2	   Inhomogeneous and functional gradient characterization .... 103	  
4.3.3	   Remarks ............................................................................... 104	  
4.4	   Experimental characterization of sheep native ACL, patellar 
tendon, patellar tendon autograft explants and engineered BLB 
explants ...................................................................................... 106	  
4.4.1	   Uniaxial tension tests and knee laxity analysis ..................... 107	  
4.4.2	   Results from uniaxial tension tests in the 6-month study ..... 110	  
4.4.3	   Results from knee laxity and uniaxial tension tests in the 9-
month study ......................................................................... 115	  
4.4.4	   Viscoelastic characterization ................................................ 117	  
4.4.5	   Summary of the 6-month and 9-month studies .................... 119	  
4.5	   Experimental characterization of sheep ACL bundles ................ 124	  
4.5.1	   Experimental setup: anterior tibial translation and bundle 
uniaxial tension tests ........................................................... 125	  
 viii 
4.5.2	   Full-Field strain contours of the native ACL during ATT ....... 127	  
4.5.3	   Mechanics of the AM bundle and PL bundle ........................ 128	  
4.5.4	   Remarks ............................................................................... 131	  
4.6	   Summary ..................................................................................... 131	  
4.7	   References .................................................................................. 132	  
CHAPTER 5	  
Computational Modeling of Native and Engineered Ligaments and 
Tendons I. Constitutive models .......................................................... 141	  
5.1	   Current constitutive Models for Ligaments and Tendon ............. 142	  
5.1.1	   Generalized Maxwell model ................................................. 142	  
5.1.2	   Quasi-Linear Viscoelastic (QLV) Model ................................ 143	  
5.1.3	   Schapery’s single integral nonlinear model .......................... 144	  
5.2	   Micromechanical Modeling of Non-Linear Viscoelasticity ........... 145	  
5.2.1	   Flexible chain models ........................................................... 147	  
5.2.2	   Semi-flexible chain models ................................................... 148	  
5.2.3	   Arruda-Boyce 8-chain network model for 3D deformation .... 149	  
5.2.4	   3D Non-linear viscoelastic model ......................................... 152	  
5.3	   Determination of the Parameters of the five-element model ...... 159	  
5.4	   Predicted biomechanical properties of native and engineered 
ligaments and tendons using the nonlinear 5-element model .... 160	  
5.5	   Conclusions ................................................................................ 165	  
5.6	   References .................................................................................. 165	  
CHAPTER 6	  
Computational Modeling of Native and Engineered Ligaments and 
Tendons  II. Finite Element Modeling ................................................. 170	  
6.1	   Current understanding ................................................................ 170	  
6.2	   The establishment of inhomogeneous ACL bundle geometries . 171	  
6.3	   FE model prediction of ACL strain contours during uniaxial tension 
testing ......................................................................................... 173	  
6.4	   FE model prediction of strain contours of the ACL during ATT .. 178	  
 ix 
6.5	   Summary ..................................................................................... 179	  
6.6	   References .................................................................................. 180	  
CHAPTER 7	  
Conclusions and Future Directions .................................................... 182	  
















List of Figures 
Figure 1.1 An ACL reconstruction procedure using patellar tendon autograft to 
replace the torn ACL. ............................................................................ 2	  
Figure 2.1 Anatomical structure of a human knee [92]. ....................................... 10	  
Figure 2.2 ACL insertions and bone attachment on femur (A) and on tibia (B) [4].
 ............................................................................................................ 11	  
Figure 2.3 Schematic drawing represents changes in the shape and the tension 
of the ACL in extension and flexion due to the femur attachment. ..... 12	  
Figure 2.4 Collagen fascicle structure in tendons and ligaments [95] ................. 13	  
Figure 2.5 A representative load vs. displacement curve (left) and the nominal 
stress vs. strain curve (right) of a typical dense connective tissue 
(tendon or ligament). Figures adapted from Woo et al., 1999 [43]. .... 20	  
Figure 3.1 Fabrication, implantation, and explantation of 3D Bone-Ligament-Bone 
(BLB) constructs engineered in vitro for Medial Collateral Ligament 
Replacement. (A) BLB construct just prior to implantation; 
approximately 3 days after detachment of the monolayer, the cells self 
organized into a cylinder. Total length of the construct pin to pin = 15 
mm; diameter = 0.47 mm. (B) 3D BLB from image (A) placed inside 
silicone tubing and secured in replacement of excised MCL; (C) 3D 
BLB construct four weeks following implantation. The presence of the 
silicone tubing makes it easy to visualize and excise the implanted 
construct; following one month of implantation, the engineered BLB 
has fused with the bone at the femur and tibia and increased in 
diameter to 0.53 mm. (D) 3D BLB excised from bone to be used for 
histology [53]. ..................................................................................... 50	  
Figure 3.2 Histological evaluation of the 3D BLB construct developed in vitro. (A): 
H&E staining. (B) and (D): collagen 1 immunostaining (red) of the end 
of the construct. (C) and (E): collagen 1 (red) immunostaining of the 
 xi 
middle part of the construct. (F): elastin immunostaining (red) of the 
middle part of the construct. DAPI staining (blue) was used to visualize 
the nuclei [53]. .................................................................................... 55	  
Figure 3.3 H&E staining of areas of native bone/ 3D BLB construct interfaces at 
the tibia (A-B) and femur (C-D) sides after 2 months of implantation 
[53]. ..................................................................................................... 56	  
Figure 3.4 H&E staining of the middle part of the 3D BLB construct after 2 
months of implantation (A-C) and native MCL ligament from 21 day old 
neonatal (D) and from adult (E) rat [53]. ............................................. 56	  
Figure 3.5 Immunostaining of the middle part of 3D BLB construct after 2 months 
of implantation (A and B) and native MCL ligament from 21 day old 
neonatal (C) and from adult (D) rat with antibodies against collagen 1 
(red). DAPI staining (blue) was used to visualize the nuclei [53]. ....... 57	  
Figure 3.6 Immunostaining of the middle part of 3D BLB construct after 2 months 
of implantation (A and B) and native MCL ligament from 7 day old 
neonatal (C) and from adult (D) rat with antibodies against CD31 (red) 
to visualize blood vessels. DAPI staining (blue) was used to visualize 
the nuclei. WGA lectin-fluorescein (green) was used to visualize the 
general tissue structure [53] ............................................................... 57	  
Figure 3.7 Immunostaining of the middle part of 3D BLB construct after 2 months 
of implantation (A) and native MCL ligament from 7 day old neonatal 
(C) and adult (E) rat with antibodies against elastin (red). DAPI 
staining (blue) was used to visualize the nuclei. WGA lectin-fluorescein 
(green in B, D and F) was used to visualize the general tissue 
structure in 3D BLB construct (B), 7-day old neonatal (D) and adult (F) 
rat [53]. ............................................................................................... 58	  
Figure 3.8 Fabrication process of a BLB construct in vitro. BMSCs were first 
isolated from sheep femurs (Step [1]). Cells were proliferated and 
differentiated into bone-like cells and ligament-like cells using growth 
media and growth factors (details can be found in the Methods Section 
(Step [2]).   Bone cells were seeded onto 35 mm cell culture plates. 
 xii 
Cells became confluent and a bone monolayer was formed on each 
dish (Step [3]). Ligament cells were seeded onto 100mm cell culture 
plates. In the same fashion, cells became confluent and a large 
ligament monolayer was formed on each dish (Step [4]). The bone 
monolayers were transferred from the current culture dishes to Sylgard 
coated dishes with two minutien pins placed on the monolayers 
approximately 20 mm apart to guide the formation of 3-D bone 
constructs (Step [5]). The ligament monolayers were carefully 
transferred to Sylgard coated 100mm dishes. Two of the engineered 
bones previously described were pinned on top of a ligament 
monolayer, and in-line axially so that the inner ends were 30-40 mm 
apart, to fabricate a 60-80 mm long BLB (Step [6]). Within one week of 
implantation eight of these constructs were pinned together laterally at 
their bone ends. Constructs fused together laterally to form a larger 
width construct with dimensions of approximately 60 to 80 mm long, 
2.8 to 3.2 mm in diameter (Step [7]). The BLB constructs did not 
develop a necrotic core during this period of time in vitro. The BLB 
constructs were then used for implantation as a sheep ACL 
replacement (Step [8]) [67]. ................................................................ 62	  
Figure 3.9 Arthroscopic ACL replacement in sheep utilizing BLB constructs and 
PT autografts. In vitro BLB construct prior to the surgery (A) has a total 
length of 70 mm including a 30 mm long ligament portion and two 20 
mm long bone ends. A freshly harvested PTG (B) is about 11 cm long 
and 4-5 mm wide prior to the surgery. Both surgeries were done 
arthroscopically without utilizing interference screws for fixation (C). 
The landmarks of the ACL insertions on femur and tibia were located 
(D). Then the ACL was removed and the tunnels (E, F) were drilled 
through the insertion landmarks. The BLB construct (G) or PTG (I) was 
guided through the tibia and femur tunnels using the suture attached 
to the proximal ends of the grafts. ...................................................... 64	  
 xiii 
Figure 3.10 BLB construct in vitro (A) 30-40 mm in intra-articular length by 
7.1±1.0 mm2 CSA, [N=7]; BLB explant in vivo at (B) two: 17 mm long 
by 14 mm2 CSA [N=1], (C) three: 18 mm long by 28 mm2 CSA [N=1] 
(D) four: 18 mm by 64 mm2 CSA [N=1] and (E) six months: 16.3±1.1 
mm long by 57.5±48.7 mm2 CSA [N=4]; native adult ACL: 18.5±0.8 
mm long by 27.7±4.3 mm2 CSA [N=3] (F) [67]. .................................. 66	  
Figure 3.11 Section of bone (A and B) and ligament (C) portions of BLB construct 
before implantation stained with antibody against collagen type 1 (red 
in A-C) and nuclear stain DAPI (blue in A-C). Arrows show area of the 
newly formed bone with cells trapped in the collagen-rich matrix. ..... 67	  
Figure 3.12 H&E staining of cross-sections of BLB explants after six months of 
implantation in vivo as an ACL replacement (A, B, C and D) and of 
native adult ACL (E). The center of section (A and B) made from 
frozen BMSCs contained viable cells and was highly vascularized but 
did not have well formed collagen fascicles. The cross section (C) 
made from fresh cells suggests possible collagen fascicle formation.  
Explant (D) made from fresh cells also appeared to have fully 
remodeled with collagen fascicle size and structure that very closely 
resembled that seen in adult native ACL in (E). ................................. 68	  
Figure 3.13 Longitudinal sections of BLB explants after (A-C) three, (D-F) four, 
and (G-I) six months of implantation in vivo as an ACL replacement. 
(A, D & G) H&E staining for visualization of general structure and 
collagen fibers; (B, E & H) CD31 immunostaining for visualization of 
blood vessels; (C, F & I) NCAM immunostaining for visualization of 
nerves. ................................................................................................ 70	  
Figure 3.14 Longitudinal sections of neonatal and adult native sheep ACL. 
Pictures of (A-C) one day old, (D-F) 14 day old and (G-I) adult sheep 
ACL are shown. (A, D & G) H&E staining for visualization of general 
structure and collagen fibers; (B, E & H) CD31 immunostaining for 
visualization of blood vessels; (C, F & I) S-100 immunostaining for 
visualization of nerves. ....................................................................... 70	  
 xiv 
Figure 3.15 BLB explant / native bone interface two months after implantation in 
vivo as an ACL replacement. Two sections of the BLB explant shows 
(A) integration into native bone through the Sharpey’s fibers (arrow) 
and (B) fibrocartilaginous region with aligned nuclei (arrow). ............. 71	  
Figure 3.16 H&E staining of cross-sections of BLB explants after 9 months in vivo 
as an ACL replacement (A) and of native adult ACL (B). The center of 
section (A) appeared to have fully remodeled with collagen fascicle 
size and structure that very closely resembled that seen in adult native 
ACL in (B). .......................................................................................... 72	  
Figure 3.17 Longitudinal sections of native ACL (A-C), BLB explants (D-F) and 
PTG (G-I) after 9 months in vivo as an ACL replacement. (A, D & G) 
H&E staining for visualization of general structure and collagen fibers; 
(B, E & H) CD31 immunostaining for visualization of blood vessels; (C, 
F & I) NCAM immunostaining for visualization of nerves. All images 
have the same scale bar. Scale bar = 0.05mm. ................................. 73	  
Figure 3.18 Longitudinal sections of BLB (A) and PTG (B) after 9 months in vivo 
as an ACL replacement immunostaining for elastin. All images have 
the same scale bar. Scale bar = 0.05mm. .......................................... 73	  
Figure 3.19 Cross-sectional sections of ACL (A), BLB (B) and PTG (C) after 9 
months in vivo, and longitudinal sections of ACL (D) and BLB (B) 
immunostaining for lubricin. All images have the same scale bar. Scale 
bar = 0.05mm ..................................................................................... 74	  
Figure 3.20 Y-Chromosome PCR assay sensitivity test (A) showed the Y-
chromosome locus Ucd043 (upper band) was reliably detected from 
dilutions of 100, 25 and 5 pg of male ovine DNA.  The lower band 
corresponds to the ZFY/ZFX locus present on both X- and Y-
chromosomes and acts as an internal PCR control. Y-Chromosome is 
undetectable in BLB Explants by PCR Analysis (B). Lanes 1-3, 
genomic DNA from BLB explants; lane 4, no template; lane 5, genomic 
DNA from female sheep; lane 6, genomic DNA from male sheep; lane 
7, no template; lane 8, 1 Kb Plus DNA Ladder (Invitrogen). Reactions 
 xv 
contained 25 ng of template DNA.  Upper band corresponds to 
Ucd043 PCR product which is specific to the Y-Chromosome and 
lower band corresponds to the ZFY/ZFX positive control. .................. 75	  
Figure 4.1 Nominal stress versus nominal strain cyclic response curves for in 
vitro 3D BLBs, 3D BLB explants and 14-day native MCLs. (A) Stress-
strain response of the in vitro 3D BLBs shows that the non-linear cyclic 
response includes a toe region, strain hardening and hysteresis. (B) 
Stress-strain response of 3D BLB explants after 4 weeks as MCL 
replacement tissues on a stress scale that is (approximately) twice that 
in (A), indicating an increase in mechanical stiffness of the construct 
during in vivo implantation.  The non-linear response includes 
hysteresis and an earlier and more gradual transition to strain 
hardening than in the in vitro BLBs. (C) Stress-strain response of 
native 14-day neonatal MCL shows similar non-linear stress-strain 
cyclic behavior to that observed in the 3D BLB explants. ................. 102	  
Figure 4.2 Comparison of tangent stiffness, average diameter and cross 
sectional area of in vitro 3D BLBs, 3D BLB explants and 14-day native 
MCLs. ............................................................................................... 103	  
Figure 4.3 Localized stress vs. strain analysis of 3D BLB constructs in vitro (A), 
3D BLB explants (B) and native rat MCL (C) with corresponding 
regions shown in the specimen photos. Developed for four weeks in 
vitro 3D BLB constructs show uniform strain response. After one 
month of implantation, strain responses are localized in 3D BLB 
explants, showing a functional gradient that is also indicated in native 
MCL. Regions that are closer to bones are relatively more compliant 
than the ligament mid-sections in both 3D BLB explants and native 
MCLs. ............................................................................................... 104	  
Figure 4.4 Customized anterior drawer tester designed and fabricated to 
measure the in vitro knee laxity at a 45 degree knee flexion angle.  
The tibia grip was fixed at 0 degrees and the femur grip was fixed at 
45 degrees. A force was applied perpendicular to the tibia shaft from 
 xvi 
the MTS at a displacement rate of 0.5mm/s. Once the force reached 
50 N, the displacement of femur and tibia location was recorded to 
measure knee anterior tibia translation. ........................................... 109	  
Figure 4.5 Speckle patterns on the tissue surface to facilitate accurate tissue 
local deformation measurement. The pattern on (A) is generated by 
spraying Blue Kote Aerosol on the surface of the tissue. The pattern 
on (B) is generated by attaching a pre-patterned tattoo transfer to the 
surface of the tissue. ........................................................................ 110	  
Figure 4.6 Stiffness of BLB explants after implantation and contralateral ACLs at 
six months of adult sheep. (A) Tangent modulus of the linear portion of 
the stress-strain response curves over a strain range of 0.10 to 0.35. 
(B) Corresponding geometric stiffness (C) Stress-strain relationship 
and (D) Load-displacement curves detailing the initial responses 
(physiological or <5% strain) of BLB explants and adult CL ACL. .... 113	  
Figure 4.7 Representative stress - strain response curves of a patellar tendon 
and an ACL from the same animal. .................................................. 114	  
Figure 4.8 Knee laxity measurements from anterior drawer tests show no 
significant difference between the BLB knee after 9 months and the 
contralateral ACL knee. There are significant differences between the 
PT autograft (PTG) receiving knee after 9 months and the contralateral 
ACL knee, and between the PT autograft receiving knee and BLB 
knee after 9 months. ** p<0.025, *** p<0.001 ................................... 114	  
Figure 4.9 Geometric stiffness (A) and tangent modulus (B) of BLB before, and 
after 9 months in vivo, PTG after 9 months in vivo, contralateral ACLs 
and PTs of adult sheep. Geometric stiffness of the force-displacement 
curves was measured over a displacement range of 0.6 mm to 2.0 
mm. Tangent modulus of the stress-strain curves was measured over 
a strain range of 0.04 to 0.08. ........................................................... 116	  
Figure 4.10 Full-field displacement contours of native ACL (A), BLB explant after 
9-month recovery (B), native PT (C) and PTG after 9-month recovery. 
 xvii 
The contours are presented at the same strain magnitude with the red 
color representing the highest strain (10%). ..................................... 117	  
Figure 4.11 Spray were applied to the surface of the ACL (A) and BLB (B) for 
displacement markers. ..................................................................... 118	  
Figure 4.12 Stress relaxation as a function of initial strain for animal-matched (A) 
ACL and (B) BLB explant in adult sheep at 6 months and (C) adult 
patellar tendon. ................................................................................. 119	  
Figure 4.13 The twisted (A) and double-bundle (B) features of the sheep ACL. 
(A) a posterior view of the sheep ACL; (B) the distinction between the 
anterior and posterior bundle after the tibia was internally rotated 90 
degrees. ............................................................................................ 125	  
Figure 4.14 Experimental setup of the anterior tibial translation test ................ 126	  
Figure 4.15 Sheep anterior bundle and posterior bundle separation: (A) the cut 
made on the tibia to release the anterior bundle from the rest of the 
ACL; (B) the posterior bundle and anterior bundle geometry. .......... 127	  
Figure 4.16 Full field strain contours of the ACL during an anterior tibial 
translation test: (A) Normal strain in y direction (force direction); (B) 
Normal strain in x direction; and (C) in-plane shear strain. .............. 128	  
Figure 4.17 Average stress-strain responses from the anterior bundle and 
posterior bundle of the same ACL. ................................................... 129	  
Figure 4.18 Full-field strain contours of the anterior bundle of the ACL during an 
uniaxial tension test: (A) Normal strain in y direction (force direction); 
(B) Normal strain in x direction; and (C) in-plane shear strain. ......... 129	  
Figure 4.19 Full-field strain contours of the posterior bundle of the ACL during an 
uniaxial tension test: (A) Normal strain in y direction (force direction); 
(B) Normal strain in x direction; and (C) in-plane shear strain. ......... 130	  
Figure 5.1 Generalized Maxwell model ............................................................. 143	  
Figure 5.2 Schematic illustration of a freely jointed chain ................................. 147	  
Figure 5.3 The effect of persistence length on the force vs. extension response of 
a MacKintosh single chain model. .................................................... 149	  
 xviii 
Figure 5.4 An eight-chain network model with eight nonlinear single chains 
resembles the microstructure of the extracellular matrix found in a 
ligament or tendon. ........................................................................... 150	  
Figure 5.5 Representative stress-strain response curves of a MacKintosh 8-chain 
model, Gaussian model, and a FJC model (A); (B) shows the low-
stretch responses of these models. .................................................. 152	  
Figure 5.6 By substituting the linear springs in a standard three-element model 
(A) with nonlinear springs, a nonlinear solid model (B) can be used to 
capture the nonlinear viscoelastic responses of soft tissue. ............. 153	  
Figure 5.7 Micromechanical modeling of engineered in vitro BLB constructs (A), 
engineered one-month in vivo BLB constructs (B) and 14-day old rat 
neonatal MCL (C). ............................................................................ 155	  
Figure 5.8 By switching the locations of the MacKintosh spring and the Gaussian 
spring, the nonlinear three-element model can capture the different 
strain-dependent relaxation behaviors of ligaments and tendons .... 156	  
Figure 5.9 Model predictions from literature results in (A) ligament and (B) tendon 
[1, 2]. ................................................................................................. 157	  
Figure 5.10 Bi-linear stress relaxation response of a native ACL ..................... 158	  
Figure 5.11 A five-element nonlinear viscoelastic 3D constitutive model .......... 158	  
Figure 5.12 Parameter fitting scheme of the proposed five-element viscoelastic 
constitutive model ............................................................................. 159	  
Figure 5.13 Experimental and computational responses of a native ACL (A, B), 
engineered BLB explant after 9-month (C, D), PTG explant after 9-
month (E, F), and native PT (G, H). .................................................. 161	  
Figure 5.14 Experimental and computational responses of the anterior (A and B) 
and the posterior bundle (C and D) from the same sheep ACL. ...... 162	  
Figure 5.15 Functionally graded prediction of the anterior bundle of the native 
ACL. .................................................................................................. 163	  
Figure 5.16 An anisotropic representative volume element for a network of semi-
flexible chains [27, 28] ...................................................................... 164	  
 xix 
Figure 6.1 FE model establishment of the anterior bundle (A,B) and the FE 
posterior bundle (C, D). .................................................................... 173	  
Figure 6.2 An FE model of the ACL anterior bundle in a twisted configuration (A) 
matched the geometry of an actual ACL anterior bundle (B). .......... 173	  
Figure 6.3 The reduced polynomial constitutive model predicts the average 
stress-strain responses of anterior bundle (A) and posterior bundle (B), 
the regional stress-strain responses of the proximal (C), mid-
substance (D), and distal portions (E) of the anterior bundle. .......... 175	  
Figure 6.4 The full-field strain contour predicted from a homogeneous anterior FE 
model (A) does not match the experimentally obtained full-field strain 
contour (B). After dividing the FE model into sub-groups, the predicted 
full-field strain contour (C) resembles that of the experimental results.
 .......................................................................................................... 176	  
Figure 6.5 The transverse strain contour of the anterior FE model (B) did not 
match that of the experiments (A). ................................................... 177	  
Figure 6.6 A homogeneous isotropic posterior FE model well predicts the strain 
contours along the testing axis (B) compared to that of the 
experimental full-field strain contour (A). .......................................... 177	  
Figure 6.7 In-plane strain contours (A-C) of an actual ACL during ATT compared 
to the in-plane strain contours of the anterior FE model (D-F). A and D 
represents the transverse strain contour; B and E represents the in-
plane shear strain contour; C and F represents the strain contour 






Lists of Tables 
 
Table 2.1 Summary of the four sequential phases occurring after ACL rupture 
according to [17] ................................................................................. 25	  
Table 4.1 Summary of the human ACL biomechanical properties including 
geometric stiffness and tangent modulus from previous studies. (* 
Numbers are reported as Mean ± SD; ** Numbers are reported as 
Mean ± SEM; numbers in red are estimated values using average 
values of ACL length (38 mm) and cross sectional area (58 mm2) from 
the literature. No standard deviations were reported on these 
estimated values.) .............................................................................. 87	  
Table 4.2 Summary of the human ACL biomechanical properties including 
maximum load, maximum stress (strength) and maximum strain from 
previous studies. (* Numbers are reported as Mean ± SD; ** Numbers 
are reported as Mean ± SEM; numbers in red are estimated values 
using average values of ACL length (38 mm) and cross sectional area 
(58 mm2) from literature. No standard deviations were reported on 
these estimated values.) ..................................................................... 88	  
Table 4.3 Summary of the biomechanics of tendon grafts used as ACL 
replacements. *Data were converted from geometric properties to 
material properties based on the geometric measurements (length and 
cross sectional area) provided in the original studies. ........................ 89	  
Table 4.4 Summary of human patellar tendon studies. (* Data used was from 
Johnson 1994. ** 90 degree twist was added to the specimen. *** 180 
degree twist was added to the specimen. # There two studies used the 
same data set. Data in red are estimated values using average values 
of PT length (40 mm) from the literature and reported cross sectional 
 xxi 
area reported from the study. No standard deviations were reported on 
these estimated values; SE stands for standard error. ) .................... 91	  
Table 5.1 Strain energy density function of flexible and semi-flexible chains in the 
Arruda-Boyce 8-chain network. ........................................................ 151	  
Table 5.2 Model parameter comparison among the in vitro rat BLB, one-month 
rat BLB explant, and 14-day old neonatal rat MCL. .......................... 155	  
Table 5.3 Model parameter comparison among the native ACL, BLB explant at 9-
months, PTG explant at 9-months, and native PT. ........................... 160	  
Table 6.1 Model constants of the reduced polynomial constitutive model for all 
stress-strain responses. ................................................................... 175	  
 1 




1.1 Anterior cruciate ligament (ACL) and its tendon grafts 
The anterior cruciate ligament (ACL) is one of four major ligaments that 
stabilize the knee. It has a complicated anatomic structure, inserting into the 
medial aspect of the lateral condyle of the femur and the anterior aspect of the 
tibial plateau [1-3]. Furthermore, the ACL is composed of multiple bundles of 
collagen fibers twisted together. It performs an important biomechanical function, 
restricting the anterior-tibial translation of the knee to within a normal range of 
motion [1-4].  
 
Tears of the ACL are the most common knee injuries in sports according to 
recent statistics [7]. Knee injuries accounted for 400,000 physician office visits in 
the US in 2005 [5]. Worldwide, the proportion of knee injuries to young sports 
players that require surgery is estimated to be 17-61% [6], and in the US, knee 
injuries are now the leading cause of high school sports-related surgeries [7]. 
Without treatment to reconstruct the ACL, the patient will lose knee stability and 
experience abnormal knee kinematics. Over time, the patient may develop 
severe osteoarthritis (OA) that increases likelihood for total knee replacement [8-
10]. Therefore an ACL reconstruction is needed to restore normal knee function. 
The current treatment is to use a tendon graft to replace the torn ACL. The 
rationale for this approach is that the microstructure of tendons is considered to 
be sufficiently similar to that of the ACL. ACL reconstruction surgeries, involving 
tendon autografts (i.e. tendon grafts obtained from patients’ own tissue) or 
allografts (i.e. tendon grafts obtained from cadaver tissue), are performed in the 
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US at a rate of nearly 350,000 per year and acute care alone costs $6 billion 
annually [25]. Figure 1.1 demonstrates the ACL reconstruction procedure using a 
patellar tendon autograft [26]. In brief, the tendon graft is first procured from the 
patient (autograft) or a cadaver (allograft). Bone tunnels on the femur and tibia 
are drilled through the footprint of the ACL remnant. The tendon graft is then 
guided through the bone tunnels to replace the torn ACL. Fixation screws are 
used to secure the graft within the anatomic position in the knee with a small 
amount of tension.  
 
Figure 1.1 An ACL reconstruction procedure using patellar tendon autograft to replace the 
torn ACL. 
Outcomes for ACL reconstruction using tendon grafts are limited by graft 
availability, risk of rejection, and increased donor site morbidity. In addition, the 
region of the graft within the bone tunnel does not fully integrate with native 
tissue and the grafts are poor biomechanical matches for the ACL [7, 8, 11]. 
Graft failure rates are 25% for the youngest, most active patients [12]. Moreover, 
acute ACL injuries are increasingly becoming more prevalent in children as 
young as 12 years old, which means they have a high likelihood of developing 
OA before age 20 and living with the debilitating effects of this condition for the 
rest of their lives. Clearly there exists a need for an engineered ligament that will 
develop biochemically relevant and biomechanically compatible interfaces with 
native tissue and restore the proper biomechanics to the knee. 
 
 In recent decades, researchers have been investigating tissue 
engineering strategies that will lead to better ACL surgical outcomes. Current 
tissue engineering methodologies utilize various biocompatible scaffolds, 
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fibroblasts or mesenchymal stem cells, and growth factors that promote cell 
proliferation and differentiation to engineer grafts in vitro [13-15]. While these 
tissue engineered scaffolds have many advantages, limitations such as 
undesirable degradation rates of the scaffolds, immediate cell death after 
implantation, and mis-matched biomechanical properties hinder their ability to 
develop into a mature tissue that can replace the native ACL [16]. Therefore, 
there is a need to improve the current tissue engineering strategies so that the 
engineered graft can be biocompatible, is capable of fully integrating to native 
bone, rapidly remodels in vivo, and ultimately matches native biomechanical 
properties.   
 
1.2 Characterization of ligaments and tendons 
In order to understand and evaluate the efficacy of tissue engineered grafts, 
we need to provide means to characterize the mechanical responses of native 
and engineered ligaments and tendons experimentally, to establish constitutive 
models that describe accurate mechanical responses of these tissues, and to 
construct a finite element model that is integrated with accurate geometry and 
constitutive relationships provided by the previous steps.  
1.2.1 Experimental characterization 
A variety of mechanical experiments is carried out with the aim of 
understanding and evaluating the functions and biomechanical properties of the 
ACL, tendon grafts, and tissue engineered grafts. Extensive human cadaver 
studies and animal studies have been conducted to elucidate their biomechanics 
[17-21]. Several types of experiments, including laxity tests, in situ force tests, 
uniaxial tension tests, and viscoelastic tests, have been conducted to study the 
tissues’ functional properties and nonlinear viscoelastic mechanical behaviors. 
Although these tests are standard, because of the intrinsic properties of these 
tissues such as anisotropy, inhomogeneity, and multi-directional fiber orientation, 
experiments that take these limitations into consideration are needed to elucidate 
the biomechanical properties of the soft tissues.  
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1.2.2 Constitutive models 
Once measurements are obtained from experiments, the information can 
then be used to establish constitutive relationships for native and engineered 
tissues in order to (1) evaluate whether current tendon grafts or tissue 
engineered grafts have optimal mechanical function for implantation and utility for 
regenerative medicine and (2) establish stress-strain relationships to prescribe 
accurate tissue response in finite element studies. The quasi-linear viscoelastic 
(QLV) formulation by Fung 1972 and a modified constitutive model based on the 
QLV theory have been used extensively to quantify the nonlinear viscoelastic 
properties of the tissue [22]. However, recent studies have demonstrated that 
these QLV based models do not fully describe the viscoelastic behaviors of 
ligaments and tendons at lower strain or stress ranges. Other models have been 
proposed to capture the viscoelastic responses of ligaments and tendons, such 
as the modified superposition theory by Provenzano et al., 2002 and Oza et al., 
2003 [23, 24]. While these curve-fitting models capture the ligament and tendon 
responses, it is important to realize that the mechanical responses of these 
tissues are modulated by the content and morphology of structural proteins such 
as type I collagen and elastin, other molecules such as glycosaminoglycans, and 
fluid. Therefore, microstructural constitutive models ultimately can provide a 
better relationship between the mechanical response and the microstructure of 
the tissue using physically relevant parameters.  
1.2.3 Finite element models 
Constitutive information can then be fed into a finite element model to study 
the mechanical responses of the tissues in 3D physiological settings. Eventually, 
the finite element model can be a useful tool to provide much insight into the 
function and failure mechanisms of native and engineered ligaments and 
tendons.  
 
1.3 Aim and outline of this thesis 
For my dissertation, I have pursued a paradigm for ACL reconstruction 
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pioneered in our laboratory that involves in vitro tissue engineering of a scaffold-
free multi-phasic construct from bone marrow stromal cells (BMSC). The 
innovative aspects of this approach include the scaffold-free technology itself, the 
development of a patient-specific, off-the-shelf technology for complete ACL 
recovery, an engineered interface between the intra-articular region and the bone 
in vitro, engineered bone ends for placement into the bone tunnel regions that 
fully integrate with the native tissue,and a redesign of the mechanical properties 
needed at the time of implantation for the intra-articular region to reduce or 
eliminate the body's initial degradation of the reconstructed tissue, and to quickly 
and completely restore the original biomechanics to the knee joint.  
 
The aim of this work is to understand and describe the biomechanics of 
native and engineered ligaments and tendons both experimentally and 
constitutively, and to examine the biomechanical responses of the native ACL, 
tissue engineered ACL, and tendon grafts in a 3D physiological setting in the 
knee joint. To achieve this aim, we designed and fabricated tissue engineered 
bone-ligament-bone constructs. The efficacy of their ability to replace native 
tissue was demonstrated as a native tissue replacement in rat and sheep 
models. We then designed and conducted experiments that characterize the 
nonlinear viscoelastic mechanical properties of native and engineered ligaments 
and tendons taking the inhomogeneous geometry of the native tissue into 
consideration. Furthermore, we established a physiologically relevant constitutive 
model to analytically describe the nonlinear viscoelastic properties of native and 
engineered ligaments and tendons. Finally, we have implemented the 
microstructural-based constitutive model into a 3D finite element setting to 
understand the biomechanical response of these tissues in a complicated 
physiological loading condition.  
 
In this thesis, Chapter 2 presents a review of the current understanding of 
the anatomy of the native ACL, the ACL tear mechanism, and current ACL 
reconstruction approaches. The subsequent chapters of this thesis present the 
 6 
four main building blocks of this work. In Chapter 3, we report on our scaffold-
less tissue engineered 3D bone-ligament-bone constructs fabricated to replace 
the native MCL in rat model and native ACL in sheep model. Chapter 4 details 
experiments we designed to accurately characterize the material properties of 
native and engineered ligaments and tendons. The experimental results provided 
by these experiments were then used to establish a microstructural-based 
constitutive model, presented in Chapter 5, that describes the mechanical 
responses of soft tissue from a physiological point of view.  In Chapter 6, the 
constitutive model was further developed and implemented into a finite element 
model with improved ACL geometry in the knee. This model was applied to 
reveal the biomechanical response of the native and engineered ligaments and 
tendons in complicated physiological loading conditions. The last part of this 
thesis, Chapter 7, provides a summary of the thesis along with limitations and 
suggestions for future studies that will strengthen the findings. 
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CHAPTER 2  
Background and Motivation 
 
 
The anterior cruciate ligament (ACL) is a major knee ligament that 
stabilizes the knee by connecting the femur and the tibia in the knee joint. The 
main function of the ACL is to maintain the normal range of motion during knee 
anterior-tibial translation. The ACL has a complicated anatomic structure. It is 
composed of multiple collagen bundles twisted together. Limited amount of 
vascularization and innervation are found in the ACL. Because of its intrinsic 
anatomic structure, the self-healing ability of the ACL is poor. The ACL is 
commonly injured in high impact sports during acceleration or deceleration with 
or without a direction change. Because of its poor self-healing ability, a surgical 
procedure to reconstruct the ACL is required to replace the torn ACL in order for 
patients to recover and regain normal physical activity. Without surgery, patients 
lose knee stability and experience abnormal knee kinematics. Over time, patients 
may develop severe osteoarthritis and face the possibility of needing a total knee 
replacement. Therefore, to reduce or eliminate these limitations, investigators are 
motivated to seek other solutions and strategies to reconstruct the torn ACL. 
Understanding the ACL anatomical structure, its function, and the interrelation 
between the structure and the function thus become critical for further 
investigation. 
2.1 ACL Anatomy and Function 
Ligaments and tendons are connective tissues that consist of cells and the 
extracellular matrix secreted by these cells. The major component of the 
extracellular matrix is collagen. Ligaments and tendons connect bone to bone 
(ligaments) or connect muscle to bone (tendons) and transmit forces and 
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maintain normal range of joint motion. The anterior cruciate ligament (ACL) is 
one of four major knee ligaments and it resides in the intra-articular region of the 
joint (Figure 2.1). In addition to its complicated bone-ligament interfaces, the 
ligament portion of the ACL has a complex, inhomogeneous geometry. This 
complex structure leads to its nonlinear, anisotropic, and viscoelastic 
biomechanical properties.   
 
Figure 2.1 Anatomical structure of a human knee [92]. 
 
2.1.1 Macroscopic anatomy of the ACL 
The ACL originates from the posterior aspect of the lateral femoral 
condyle and inserts into the lateral aspect of the tibia plateau. Furthermore, the 
ACL twists on itself in a slight lateral spiral [1, 2]. The ACL attaches to the femur 
and tibia as a collection of individual fascicles that fan out over a broad flattened 
area. These fascicles are oriented in different directions. Some fascicles are 
orientated in a spiral pattern along the long axis of the ACL; others are directly 
connected from femoral to tibial attachment [1]. Hara et al., 2009 traced these 
fascicular structures and they demonstrated that these fascicles twist around 
each other when the knee flexes [3]. Specifically, the ACL is attached to the 
posterior aspect of the medial surface of the lateral femoral condyle with a semi-
elliptical footprint shape (Figure 2.2 A) [4]. The ACL fans out as it approaches the 
tibia. It then attaches to the depressed area of the anterior and lateral aspect of 
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the tibia with an irregular footprint (Figure 2.2 B) [4]. The depressed area is 
approximately 11 mm wide and 17 mm antero-posteriorly [2, 4, 5]. The shape 
and area of the cross section of the ACL changes along the long axis of the ACL 
[2]. The cross sectional area of the ACL is the smallest near the femoral insertion 
site and the largest near the tibial insertion site [2]. This suggests that the tibial 
attachment of the ACL would be stronger than the femoral attachment if the 
material properties were uniform along the length of the ACL [6]. When the knee 
is in the extended position, the ACL is flat. When the knee is flexed, the ACL 
begins to wind and bundles become twisted around one another  (Figure 2.3). 
The average length and width of the ACL reported from the literature are 32 mm 
and 11 mm, respectively [5]. 
 
Figure 2.2 ACL insertions and bone attachment on femur (A) and on tibia (B) [4]. 
 
Because of the complicated bone attachments of the ACL, not all of its 
fascicles present the same tightness or looseness at the same knee flexion angle 
[4], suggesting these fascicles may be divided into functional groups for better 
ACL functional and biomechanical response. Chhabra et al., 2006 demonstrated 
that the fetal human ACL has separate fiber bundles during embryogenesis [7]. 
This separation is found consistently in old age [8, 9]. Therefore, investigators 
have treated the structure of the ACL as separate fascicle bundles. While 
Norwood and Cross 1979, Rosenburg and Rasmussen 1984, and Amis et al., 
1991 have treated the ACL as three functional bundles, - anteromedial, 
intermediate, and posterolateral [5, 8, 10], Girgis 1975 and Arnoczky 1983 have 
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divided the ACL into two bundles - the anteromedial bundle (AMB) and the 
posterolateral bundle (PLB) [4, 6]. The AMB originates at the most anterior and 
proximal aspect of the femur and inserts at the anteromedial aspect of the tibia, 
while the PLB originates at the postero-distal aspect of the femor and inserts at 
the posterolateral aspect of the tibial attachment [4]. The PLB contains more 
collagen fibers than that of the AMB [5]. The less common three-bundle 
treatment first also divides the ACL into anterior and posterior bundles. The 
anterior bundle is then subdivided into medial and lateral halves [11, 12].  
 
While both characterizations are applied to the ACL, the two bundle 
separation is found to be more widely accepted and used to characterize the 
ACL, and is supported by recent arthroscopic analysis performed by Steckel 
2009 [13] and the well-defined two-bundle structure found in fetal ACLs [14]. 
  
Figure 2.3 Schematic drawing represents changes in the shape and the tension of the ACL 
in extension and flexion due to the femur attachment.  
 
During knee extension, the two bundles run relatively parallel to one 
another. During knee flexion, the AMB spirals around the PLB [2]. This is due to 
the femoral attachment of the ACL and the significant length differences in the 
two bundles, which leads to complex, non-uniform strain patterns on the ACL 
bundles in various knee positions [15]. As the knee is extended the PLB is 
strained, while the AMB is lax. As the knee is flexed, the femoral and tibial 
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attachments of the PLB move closer to each other, resulting in a PLB that is 
unloaded and lax. On the contrary, the attachments of the AMB move away from 
each other during flexion, causing the AMB to become taut and strained [4, 6]. 
Arnoczky 1983 also noted that the afroementioned description oversimplifies the 
orientation of the ACL. The ACL is a continuum of fascicles and in any position of 
knee flexion-extension, there is always a portion of the ACL that remains under 
tension and provides knee stability [6].The fascicles from the convex border form 
the medial side of the ligament and are attached to the anterior tibial spine. They 
stand out as a thin single band. This band is tense in flexion [4].  
 
2.1.2 Micro anatomy of the ACL 
Like other dense connective tissue, the ACL consists of cells and an 
extracellular matrix secreted and maintained by these cells. The major cell type 
in the ACL is spindle-like fibroblasts. The round or ovoid shaped cells that 
resemble chondrocytes (commonly present in fibrocartilage) are also found in the 
ACL [16]. Myofibroblasts-like cells (commonly present in muscle) that contain 
alpha-smooth muscle actin are also found in the midsubstance of the intact 
human ACL [17]. The extracellular matrix of the ACL is composed of four 
different constituents, namely collagen (Type I collagen dominates with limited 
amounts of type II, III, IV and VI collagen), glycosaminoglycans (GAGs), glyco-
conjugates (laminin, entactin, tenascin, and fibronectin), and elastin [2].  
 
Figure 2.4 Collagen fascicle structure in tendons and ligaments [95] 
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The major component in the extracellular matrix of the ACL is collagen. 
The structure of collagen can be described hierarchically [1]. As shown in Figure 
2.4, the ACL is made up of multiple fascicles that can be grouped into bundles 
(AMB and PLB) as described previously. The substructures within these fascicles 
are collagen fibrils that have a large range of diameters. The smallest diameter 
reported is 25 nm [18], and the largest 250 nm [1, 2, 16]. These collagen fibrils 
form nonparallel, interlacing networks, and the fibrils are grouped into fibers that 
have 1-20 µm diameters. The fibers form subfascicles with a 100-250 µm 
diameters, each surrounded by a loose band of connective tissue known as the 
endotenon. Three to twenty subfascicles bound together to form a fascicle, which 
may range from 250 µm to several mm in diameter and is surrounded by an 
epitenon. The entire continuum of fascicles is grouped into two major bundles to 
form the ACL. Another connective tissue layer, the paratenon, surrounds the 
entire ACL [1, 6].   
Strocchi et al., 1992 have characterized two types of fibrils in the ACL. 
The first type of fibril is secreted by fibroblasts, has a diameter ranging from 25 to 
85 nm, and an irregular cross section profile. This type of fibril accounts for 
50.3% of the entire ACL and is specialized to resist high tensile stresses. The 
second type of fibril is secreted by fibro-chondroblasts. It has a uniform diameter 
(45 nm) and a smooth cross section profile. This type of fibril is believed to 
maintain the three-dimensional organization of the ligament [18]. Elastin is found 
abundantly in both transverse and longitudinal sections of the ACL.  
 
The cross-section of the ACL reveals collagen fascicles and connective 
sheaths. The ratio between the areas occupied by these two structures varies 
along the length of the ACL [1], suggesting the micro anatomy of the ACL may 
vary along the length of the ACL. Transmission electron microscopy images have 
revealed that the collagen fibrils located in different regions of the ACL possess 
different diameters as shown in Baek et al., 1998 [19]. In their study, collagen 
fibril diameters in the ACL from young human specimens (17-22 years) were 
found to be largest in the distal region (78.2 ± 29.7 nm) but decreases proximally 
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(middle: 74.8 ± 27.6nm; proximal: 66.1 ± 26.4nm) [19]. Duthon et al., 2005 have 
established a detailed study to characterize the microstructure of the ACL 
regionally [2]. Specifically, this study analyzes the microanatomy of the ACL by 
distinguishing the ACL into proximal, middle, and distal zones, to identify the 
extracellular components in each zone. Their key results are as follows:  
1. The proximal zone is highly cellular with round and ovoid cells. This 
zone is composed of fusiform fibroblasts, collagen type II and glycoproteins such 
as fibronectin and laminin [2].  
2. The middle zone contains fusiform and spindle-shaped fibroblasts, 
elastic and ocytalan fibers along with a high density of collagen fibers. This zone 
also contains cartilage and fibrocartilage. The fusiform and spindle-shaped 
fibroblasts are dominant. The densest zone of fibroblasts is located in the middle 
and proximal one-quarter of the ACL, with cells and blood vessels longitudinally 
oriented and high crimp length [2].  
3. The distal zone of the ACL is rich in chondroblasts and ovoid 
fibroblasts. The collagen bundle density is relatively low in this zone [2]. Petersen 
et al., 1999, demonstrated that this fibrocartilaginous zone is located 5-10 mm 
proximal of the tibial ligament insertion on the anterior portion of the ACL [16]. 
The cells in this area are chondrocyte-like. The collagen fascicles in this region 
cross each other at sharp angles [16]. The diameters of these fibrils are between 
130 to 250 nm, larger than elsewhere in the ACL [2][16]. In a knee extension 
position, the intercondylar fossa of the femur may cause a compressive strain on 
the anterior part of the ACL. Therefore, the fibrocartilage region in the ACL may 
be formed to withstand the compression generated [16, 20]. 
  
The insertion site of the ligament to bone is called the enthesis. It has a 
unique microstructure to mitigate the stress concentration as the soft ligament 
tissue transitions to hard bone. The ligament transitions to bone via a transitional 
zone of fibrocartilage and mineralized fibrocartilage [6]. The gradual structural 
alteration in the transitional zone allows for a gradual change in stiffness and 
prevents stress concentration at the attachment site [6]. Benjamin et al., 2006 
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classified the entheses into fibrous and fibrocartilaginous entheses according to 
the type of tissue present at the insertion sites [21]. At fibrous entheses, the 
tendon or ligament attaches either directly to the bone or indirectly to it via a 
structure called Sharpey’s fibers (a term used to designate collagen bundles from 
tendon/ligament microstructures penetrating to bone structure) [21, 22]. This type 
of enthesis usually connects tendon/ligament to a membranous bone. Whereas 
at fibrocartilaginous entheses, chondrogenesis occurs and four zones of tissue 
can be detected, namely pure dense fibrous connective tissue, uncalcified 
fibrocartilage, calcified fibrocartilage, and bone. This type of enthesis usually 
connects tendon/ligament to an endochondral bone [21, 22]. Though it is difficult 
to precisely define the beginning or the end of the entheses, a tidemark, the 
basophilic line separating the uncalcified zone and calcified fibrocartilage zones, 
can be identified [21]. Calcified fibrocartilage is typically less cellular than the 
uncalcified portions of the rest of enthesis. It is believed the fibrocartilage is 
differentiated from tendon/ligament cells at the enthesis by changing cell shape 
and cell-cell interactions [20, 23]. This tissue expresses cartilage markers such 
as type II collagen and aggrecan [21, 24]. All fibrocartilage associated with 
normal entheses is believed to be avascular which leads to the poor self healing 
response of the ACL at and near the attachment sites [21].  
 
The entheses of the ACL is 100 um to 1 mm in length on average 
depending on species and age [16, 25, 26]. Few studies have shown the detailed 
microstructure of the ACL enthesis. Petersen et al., 1999 detected mineralized 
fibrocartilage in both femoral and tibial entheses [16]. Scranton et al., 1998 
detected Sharpey’s fibers at the ACL graft (quadruple-hamstring) insertions in 
both sheep and human specimens as early as 6 weeks [94]. These studies 
indicate that both fibrocartilage and Sharpey’s fibers can be used to detect the 
biological anchoring formation of the ACL graft to the host bone.     
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2.1.3 Vascularization and innervation 
2.1.3.1 Vascularization  
Arnoczky 1983 summarized that the blood vessels in the ACL are likely 
from the periligamentous vessels formed by the synovial fold that covers the ACL 
[6]. These periligamentous vessels form smaller connecting branches and 
penetrate the ligament transversely with a network of endoligamentous vessels. 
The vessels, along with their supporting connective tissues, are oriented in a 
longitudinal direction and lie parallel to the collagen bundles within the ligament 
[6].   
The ACL vascular supply is not sparse even within the deepest layer of 
the ligament and it is suggested it is adequate for healing of the ligament [6, 27]. 
However, the blood distribution within the ACL is not homogenous, with better 
vasculature supply in the proximal part of the ACL than the distal part of the ACL.  
The fibrocartilagious part of the ACL is avascular [16]. This is believed to play a 
role in the poor healing potential of the ACL [2]. 
2.1.3.2 Innervation 
The ACL receives nerve fibers from branches of the tibial nerve. These 
fibers penetrate the joint capsule posteriorly and move along with the synovial 
and periligamentous vessels surrounding the ligament. Smaller nerve fibers have 
also been observed throughout the substance of the ACL. In addition, some 
singular nerve fibers without tibial origins have been found among the fascicles of 
the ligament and it is possible that these fibers contribute to sensory function by 
functioning as receptors [6, 27, 28]. Recent data also suggest these sensory 
receptors in the ACL may play an important role in the arthrokinetic reflex that 
contributes to overall neuromuscular control of the knee joint [29]. It is believed 
that the ACL reflex is essential in normal knee function [30, 31]. This feedback is 
lost in patients with a ruptured ACL, which leads to femoral weakness in the 
quadriceps [31].   
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2.1.4 ACL function 
The anatomy and spatial orientation of the ACL within the joint can be 
directly related to its function as a constraint to joint motion. For detailed 
anatomical structure of the ACL, please refer to section 2.1.1. Briefly, the femoral 
and tibial attachments of the ligament, as well as the multifascicular nature of its 
structure, allow different portions of the ligament to be taut, and therefore 
functional, throughout the range of motion [6]. Studies have been performed in 
the past few decades with the goal of elucidating the complicated function of the 
ACL [4-6, 15, 32]. Early studies examined the role of the ACL by performing an 
anterior tibial displacement or drawer test on the cadaver knee before and after 
the ACL was cut [4, 32]. When all elements in the knee are intact, detection of  
the sliding movement of the anterior femur along the tibia  is limited. However, 
when the ACL is cut and all other elements in the knee capsule were kept intact, 
the knee could easily be hyperextended. Both internal and external rotations of 
the tibia are also increased with in the absence of an intact ACL [4]. The ACL is a 
primary restraint to knee anterior tibial displacement [32 and references within]. 
The ACL is taut when the knee is in full extension and at 5 and 20 degrees of 
flexion. It becomes more relaxed between 40 and 50 degrees of flexion, and then 
becomes increasingly taut as flexion is increased from 70 to 90 degrees [6].  
 
It is suggested that the AMB of the ACL is responsible for the increase in 
antero-posterior drawer with flexion [4]. Butler, 1989 concluded that the anterior 
bundle provides all of the anterior restraining action at a 30 degree flexion angle 
[33]. Amis et al., 1991 demonstrated that the PLB contributed the most (47%) to 
force resistance measured at a 20 degree knee flexion angle. They reported that 
the posterior bundle slackens in flexion, leaving the anteromedial bundle to resist 
anterior tibial translation in the knee at 90 degree flexion [5]. Hefzy et al., 1987 
have showed that the ligament insertion portions change very little in strain 
during knee flexion-extension [34]. However, Bulter 1989 showed that if tested in 
a uniaxial tension setup, the ligament insertion site experiences more strain 
whereas in the middle there is little strain, indicating the middle portion of the 
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ACL is stiffer than that of the insertions [32]. Hollis et al., 1991 designed a 
kinematic linkage device, a 6-degree of freedom robotic system, to measure 
knee joint motion. As stated in their study, when measuring the length of each 
ACL sub-bundle, the bundles are often assumed to be a straight line connecting 
the femur and tibia. This assumption leads to an underestimation of the true ACL 
length change since the fibers are usually twisted resulting in longer contour 
lengths [15].  Hollis et al., 1991 divided the ACL into three bundles and found that 
through the 0-90 degree knee flexion span, the antero-medial (AM) bundle 
gradually lengthened while the postero-lateral (PL) bundle gradually shortened 
and the intermediate (IM) bundle did not change in length. At zero external load 
condition (30 degree knee flexion), the AM bundle was lengthened while the PL 
portion is shortened and the IM portion did not significantly change in length. 
With an anterior load, the AM portion lengthened slightly less than the PL portion 
[15]. Finally, in a recent review, Amis 2012 concluded that the AM bundle 
contributes the most to resisting tibial anterior translation, which is the primary 
function of the ACL. When the knee is at extension, the PL bundle of the ACL 
tightens so that the ACL also has a role in controlling tibial rotational laxity [35].  
  
Bach et al., 1997 implanted strain gauges in the AM and PL bundles to 
measure the changing strain during knee flexion motion [51]. They found that the 
AM bundle has very little change (<1%) from 10 to 90 degrees knee flexion while 
the PL bundle was relaxed from 40 degrees onward. At 8 degrees 
hyperextension, the AM bundle was stretched 4% beyond its initial length while 
the PL bundle elongated by 10% of its initial length [51]. The data were confirmed 
by the recent studies using 3D imaging methods in vivo. Zantop et al., 2005 
reported that after the PL bundle is dissected, anterior tibial transition became 
larger than that of an intact knee at 30 degree knee flexion after an anterior tibial 
load, but no difference was found at 60 and 90 degree knee flexions. Whereas 
after the AM bundle is dissected, the anterior tibial transition was larger than that 
of both an intact knee and the PL bundle dissected knee at 60 and 90 degree, 
but no differences were found between 0 to 30 degree knee flexion [36].           
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2.1.5 The biomechanical properties of the ACL 
 Many biomechanical studies have been performed to characterize the 
structural and material properties of the ACL. Several measurements are used to 
characterize the ACL, including geometric stiffness, tangent modulus, failure 
strength, strain to failure, and failure mode [37-42]. A typical dense connective 
tissue demonstrates a nonlinear viscoelastic stress vs. strain relationship. 
Traditionally, the mechanical properties of the ACL are characterized from a load 
to failure curve (Figure 2.5), in which load and displacement are direct 
measurements from instruments. From the load vs. displacement curve, one can 
measure the geometric stiffness - a property that is dependent on the size of 
samples tested - to ultimate load (load to failure), and ultimate displacement 
(displacement at the ultimate load). The load and displacement are then 
converted to nominal strain and nominal stress to characterize material 
properties such as tangent modulus, ultimate stress (stress to failure) and 
ultimate strain (strain at ultimate stress).  
 
Figure 2.5 A representative load vs. displacement curve (left) and the nominal stress vs. 
strain curve (right) of a typical dense connective tissue (tendon or ligament). Figures 
adapted from Woo et al., 1999 [43].  
 
The biomechanical properties of the human ACL have been extensively 
studied and study results are summarized in Chapter 4 Table 4.1 and Table 4.1. 
A detailed description of the two tables and a thorough discussion characterizing 
































found in Chapter 4. The average geometric stiffness of the human ACL is 178 
N/mm and the average tangent modulus is 106 MPa; load to failure is 1061 N 
and the corresponding strain to failure of the human ACL is 20%. The structural 
characteristics of the ACL support its function as sustaining multi-axial stress. 
Butler et al., 1992 divided the ACL using a three-bundle model and measured the 
tangent moduli of all three subunits. They found that while the strain at failure is 
quite similar (15% to 18%), the two anterior bundles failed at higher tangent 
moduli with higher maximum stresses than those of the posterior bundle [11]. 
The authors hypothesized the mechanism causing different tangent moduli in 
bundles might be the frequency of loading.  In vivo, anterior bundles are more 
frequently loaded than posterior bundles, which may lead to the development of 
the higher modulus. As discussed earlier, the microscopic anatomy of the ACL 
shows that fibrocartilage zones are found at the anterior portion of the ACL, 
which may also cause the anterior bundles to experience higher stresses. The 
fact that all bundles failed at a similar strain level suggests the ACL fails by a 
strain-dependent mechanism [11].   
 
The biomechanical properties of the ACL/bone entheses have also been 
examined recently. Four zones in the ACL entheses previously described 
(section 2.1.2) have region-dependent mechanical properties that correlate to 
their mineral contents [26]. The study also reported that the mechanical 
properties of the ACL femoral and tibial entheses are significantly different, even 
though both entheses have similar histological properties and extracellular 
component contents. It is suggested that the difference in collagen fiber 
organization in the two entheses may contribute to the insertion site-dependent 
mechanical properties [26].   
 
2.2 ACL Injuries  
Knee injuries accounted for 400,000 physician office visits in the US in 
2005 [44]. Worldwide, the proportion of knee injuries to young sports players that 
require surgery is estimated to be 17-61% [45], and in the US, knee injuries are 
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now the leading cause of high school sports-related surgeries [46]. Among all 
knee injuries, anterior cruciate ligament (ACL) injury is the most common. The 
incidence of ACL injury has been estimated at one in 3000 Americans [47]. 
These numbers are up 3-4 fold from estimates from about a decade ago and are 
increasing rapidly in pre-teens and teenagers [70].  
 
2.2.1 Diagnosis and ACL tear patterns 
Physical examination such as the anterior drawer test and the Lachman 
pivot shift test, devices designed to quantify anterior tibial translation (TK series 
arthrometer), advanced imaging (CT and MRI), and direct arthroscopic 
examination are used to assess the ACL tear [48].  
 
Even though large stress concentrations at the entheses could make the 
ACL vulnerable to acute or overuse in sports [21], ACL tears with bone avulsion 
are very uncommon [27]. The mid-portion of the ligament and the proximal end of 
the ligament near the femur were demonstrated to be the most common sites of 
ACL tears [27]. The tear site makes the reattachment of the ligament to its 
femoral origin difficult. Various types of ACL tear patterns have been 
documented including complete ruptures, and partial tears with sub-division of 
AM and PL tears. A recent study arthroscopically identified that 21.2% of ACL 
tears are partial tears. Within this subgroup, 8.6% were PL bundle tears while the 
remaining 12.6% were AM bundle tears. This study utilized 174 patients who 
underwent ACL reconstruction [49]. Another study of 169 patients recorded the 
majority had complete ACL ruptures, 13 cases had an AM bundle rupture and 4 
cases had a PL bundle rupture [50]. In a recent study, Zantop et al., 2007 
reported that among 121 patients undergoing ACL reconstructions, 25% were 
partial tears whereas the rest were complete ACL ruptures. In 44% of all patients, 
AM and PL bundles did not rupture at the same location, while 56% of the 
patients did experience AM and PL rupture at the same location, a proximal tear. 
No sign of PL rupture was observed in 12% of the patients, however, no patients 
had an intact AM bundle [65].   
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2.2.2 ACL tear mechanisms  
When the strain or stress developed along the ACL fascicles is beyond 
their limit, partial groups or the entire continuum of fascicles tear. ACL functions 
within a small range of tensile strains and typically ruptures at 20% strain [35].  
 
Approximately 70% of ACL injuries are caused from noncontact injuries 
[52]. The cause of the ACL tear has been characterized as a combination of 
external-rotation and abduction forces, or a hyperextension, or by an anteriorly 
directed force applied to the posterior aspect of the tibia. It has recently been 
suggested that ACL injury is possible via a purely sagittal plane loading 
mechanism [53]. Terauchi et al., 2011 claimed that the majority of athletes 
indicate a close to full extension knee position at the time of injury [54]. Many 
researchers speculate that a more complex three-dimensional scenario leads to 
the ACL tear [55]. Impact-induced tibiofemoral accelerations during a landing 
may cause ACL elongation to rupture [56]. Kennedy et al., 1974 suggested that 
one mechanism that causes an isolated ACL tear is an internal rotation of the 
tibia on the femur, however, this proposed mechanism cannot be reproduced in 
the laboratory using cadaver knees [27]. The orientations of ACL attachments 
are dependent on whether their point of attachment is the femur or the tibia. 
Consequently, the length of the ACL varies from its anterior aspect to its 
posterior aspect wherein the posterior bundle is shorter than the anterior bundle 
[35]. This causes the posterior bundle to suffer a greater strain than the anterior 
bundle during a tibial translation movement, thereby making the posterior bundle 
more vulnerable to rupture [11, 57].  
 
A number of knee morphologic variables have been identified as risk 
factors for ACL injury such as a small femoral notch, a higher-than-normal body-
mass index (BMI), increased joint and ACL laxity, tibial plateau depth of 
cancavity, a steep posterior tibial slope, and variations in lower limb alignment 
[58-64]. McLean et al., 2011 demonstrated a significant association between the 
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posterior tibial slope and the anteromedial bundle ACL strain for dynamic high-
impact jump landings [56]. Terauchi et al., 2011 summarized additional extrinsic 
factors such as shoe surface interaction, skill level, muscle strength and 
conditioning [54].  
 
2.3  ACL repair and its outcomes 
Because of the critical biomechanics role the ACL plays in knee function, 
abnormal kinematics caused by an ACL-deficient knee lead to further knee 
complications such as menisci tear, cartilage damage and eventually 
development of osteoarthritis. Therefore a surgical procedure to reconstruct the 
torn ACL using tendon grafts has been the standard procedure to repair a torn 
ACL. Despite the good outcomes, many limitations are also associated with the 
current ACL replacement methodology, such as donor site morbidity, graft 
availability, and mis-matched biomechanical properties between the graft and the 
native ACL.      
2.3.1 Healing of the ligament 
Tendons and ligaments that are composed of dense connective tissue 
heal the rupture site through a series of progressive events, namely 
inflammatory, proliferative, and remodeling phases [17]. As a result, a functional 
scar is formed at the wound bridging the rupture [17, 66].  Animal studies have 
shown that the MCL heals by bridging scar formation at the injury site. The 
healing process includes short phases of hemorrhage and inflammation, followed 
by a proliferation phase and then a prolonged remodeling phase [66, 67].  
Unlike the MCL, the intra-articularly located ACL does not form the scar 
mentioned above. As previously discussed, in most ACL tear incidences, the tear 
occurs in the middle or proximal third portion of the ACL[68]. Histologic and 
immunohistochemistry analysis revealed that the cells within the ACL proliferate 
and migrate easily into the wound site, the ligament vascularizes after the tear, 
and collagen production recurs within the torn ACL [69 and the references 
within]. A layer of synovial tissue over the ruptured surface forms after the ACL 
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rupture occurs. This may hinder the ligament repair. A large number of 
myofibroblasts are differentiated in this synovial layer and in the epiligamentous 
tissue, which can cause the retraction of the ruptured ACL ends [17]. However, 
because of the anatomy and the function of the ACL, the ACL remnants pass 
each other in the knee joint and never reconnect. Thus it is impossible for the 
ACL to heal itself, regardless of the blood supply and cell activity they possessed 
[69].  
 
Murray et al., 2000 described the four sequential phases of the ACL injury 
response in details. The key points of each phase are listed in Table 2.1 [17]. 
The authors pointed out that (1) the formation of a synovial layer that is abundant 
in cells expressing alpha-smooth muscle actin covers the surface of the rupture 
ends, (2) the lack of any scar tissue bridging the two ruptured ends, and (3) the 
presence of an epiligamentous reparative phase are the differences between the 
ACL response to rupture and responses of the other dense connective tissues to 
injury [17]. 




Phase Time Rupture site appearance Cellular behavior Vascularization
Inflammation  1- 2 weeks
1. no connection between the 
two ruptured ends 1. fibroblasts populated the remnant
1. dilated arteriols and 
venules
2. friable and stringy tissue that 
looks like "mop-ends"
2. inflammatory cells: neutrophils and 
macrophages
2. congested capillaries
1. covered with gradually 
growing epiligamentous and 
synovial tissue
1. unchanged cell density in ACL 1. unchanged blood vessel 
density
Epiligamentous 
Regeneration 3 - 8 weeks
2. no tissue bridging the two 
ruptured ends
2. decreased number of 
inflammatory cells in ACL
2. no neovascularization in 
ACL
3. a synovial cell layer extending 
over the ruptured site surface 
3. increased cell density in 
epiligament
3. increased blood vessel 
density in epiligament
1. increased cell number density in 
the ACL with fibroblasts dominant
Proliferation 8  - 20 weeks
a complete synovial cell layer 
covering in the distal end
2. disorganized orientation of the 
fibroblasts in the ACL
 increased blood vessel 
density in the ACL
3. abundant alpha-smooth muscle 
actin-containing cells in the synovial 
layer and throughout the ACL
Remodeling and 
Maturation  1 - 2 years
1. dense ACL remant with little 
fatty synovial tssue covering the 
surface
1. fibroblasts with nuclei aligned with 
the collagen fiber in ACL
decreased blood vessel 
density in the ACL
2. epiligamentous tissue 
covering the ACL remnant 
decreases in thickness
2. cell density in the ACL found to be 
similar to the intact ACL
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In recent years, ACL rupture in children and adolescents is on the rise. 
The long-term consequences from an ACL-deficient knee are found to be more 
significant in younger and more active individuals (details can be found in [70]). 
Therefore, early reconstruction of an ACL-ruptured knee is thought to decrease 
subsequent cartilage and meniscal injury. Because the current ACL 
reconstruction techniques involve drilling across the physeal plates of both the 
femur and tibia, treatments to children and adolescents have been complicated. 
These skeletally immature patients have wide-open physes; hence, damage to 
the physes has been a significant concern using the current drilling techniques. 
This is because one may face severe consequences such as growth 
abnormalities.  Physicians often face a dilemma in treating an ACL injury in a 
skeletally immature patient [70]. On one hand, these young patients are often 
active in sports and thereby at increased risk for suffering further intra-articular 
component damage; alternatively, a reconstruction increases risk of the 
development of growth abnormalities in the knee [70]. Therefore, the ideal 
treatment of these individuals is currently not clear.  
 
Non-anatomic physeal-sparing surgical techniques are used to address 
the needs of skeletally immature patients [70] with the goal of avoiding bone 
tunnel passing through the physis during reconstruction. Concerns are raised in 
this technique because of the non-anatomic placement of the graft that could 
potentially cause abnormal knee loading. Physicians have also used the 
standard transphyseal reconstruction techniques in these patients with the goal 
of providing maximal knee stability while hoping to not disturb the growth plates 
of the young patient [70]. Some modifications from adult ACL reconstruction have 
been made including drilling smaller tunnels, lightly packing tunnels with a soft-
tissue graft, and avoiding crossing physis with bone plugs or fixation devices [73]. 
Various grafts are used to perform the ACL reconstruction including hamstring 
autograft, iliotibial band grafts, patellar tendon grafts and quadriceps grafts [70].   
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2.3.2 Current surgical strategies 
Clinicians believe that ACL reconstruction surgeries provide additional 
knee stability and potentially protect other components within the joint. Earlier 
surgery applying suture repair to bridge the ACL remnants failed to reconstruct 
the torn ACL [69]. The reconstruction using a graft to replace the torn ACL is 
currently the universal solution to treat the torn ACL. ACL injuries occur 
frequently and have a substantial financial cost.  [71]. The most commonly used 
grafts in ACL reconstructions are patellar tendons, hamstring tendons and 
quadriceps tendons [72]. Autografts are the current gold standard for ACL 
replacements and the patellar tendon is the most common source of autograft 
tissue.  
 
2.3.3 Outcomes of the current ACL reconstruction 
The current treatment allows patients to return to rigorous activities in the 
vast majority of cases. A recent study reviewed 5770 patients who were athletes 
before ACL injury with a mean follow-up of 41.5 months and concluded that the 
ACL reconstruction has an overall high rate of successful outcomes based on the 
fact that about 90% of participants regained normal or nearly normal knee 
function (laxity and strength) [74]. However, only 63% of the participants returned 
to their pre-injury level of activity [74]. Despite the functional outcomes from the 
current surgical treatment, long-term results are not satisfactory. Other studies 
showed that many grafts function as mechanical springs that span the gap 
between the femur and tibia, providing initial stability and allowing joint motion, 
but do not complete the ligamentization process nor restore the original 
biomechanics to the knee even 2-3 years after surgery [26, 75]. Besides high 
economic cost, many limitations are associated with the current treatment. 
Specifically, autografts may result in surgical site morbidities and require a 
second surgery and possibly longer surgical procedure. Allografts carry the risk 
of transmitted diseases, are limited by donor availability, and may result in an 
immune rejection. Both graft types suffer mis-matched biomechanical properties. 
[45, 46, 75-79].  Using patellar tendon grafts, the most commonly used ACL graft, 
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as an example, its viscoelastic properties differ in several important ways from 
those of the ACL [80]: (1) the initial stiffness of the patellar tendon exceeds that 
of the ACL [81, 82], (2) the patellar tendon strain to failure at a given strain rate is 
significantly less than that of ACL, which may lead to increased failure incidences 
[81, 82], and (3) the patellar tendon failure strain is more sensitive to strain rate 
than the ACL failure strain; at higher strain rates the failure strain for the patellar 
tendon decreases rapidly [81], again leading to increased failure risks under 
impact loads. The mismatch may be critical in the generation of increased intra-
articular forces, the early onset of osteoarthritis (OA) and high failure rates (20%) 
in young, active patients [70, 83, 84], and the risk of OA development [75, 77, 78, 
85]. In addition, the incidence of early-onset OA within 7-14 years after knee 
injury is as high as 50% [78, 79, 86], without improved outcomes as a result of 
ACL reconstruction [78, 83]. 
 
A recent review demonstrated a high incidence of meniscal tears in this 
young group of patients who had ACL reconstructions. The authors concluded 
that this trend may be the result of the failure of physicians and parents of young 
patients to limit their physical activity as they wait for their skeleton to reach 
maturity [70]. Kocher et al., 2002 reported the increase in the incidence of growth 
disturbances in skeletally immature patients with ACL reconstructions [87]. In 
order to achieve successful reconstruction in this group, one must avoid trauma 
to the tibial apophysis. Another recent study reported that the combined injuries 
of ACL tears with cartilage or meniscal injury resulted in the highest incidence of 
long-term osteoarthritis [88].     
 
To overcome the limitations of tendon auto- and allografts, synthetic 
polymer devices have been attempted as replacements of the torn ACL. These 
devices include Leeds-Keio ligament (Poly-ethylene terephthalate), Kennedy 
ligament augmentation device (polypropylene) and Gore-Tex 
(tetrafluoroethylene) [89]. These synthetic devices initially have sufficient 
mechanical stiffness. However, they all failed over time because they could not 
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meet the biomechanical requirements of the ligament [89]. One reason for the 
failure might be that the cells are not attracted to the synthetic device. Therefore, 
no extracellular matrix is produced in these devices. Thus, there is a need for a 
ligament graft that will develop biochemically relevant and biomechanically 
compatible interfaces with native tissue and restore the proper biomechanics and 
physiological function to the ligament. These limitations have led investigators to 
develop strategies to engineer ligament tissue to reduce or eliminate the need for 
graft tissue altogether [90]. Tissue engineering provides opportunities for a 
paradigm shift in the treatment for a torn ACL. In recent decades, investigators 
have been focusing on tissue engineering ACL grafts to improve the outcomes of 
the ACL repair. Most cellular based approaches utilize scaffolds (biologic 
materials, biodegradable materials or composites) with or without cells seeded to 
replace ACLs [90, 91]. 
 
2.4 Summary 
The ACL has a complex anatomic structure which sustains the important 
function of the ACL in the knee joint including anterior tibial translation. Though 
ACL tears are commonly sustained during athletic activities by patients all ages; 
in recent years, the patient age at injury occurrence has declined for ACL tears. 
An ACL-deficient knee will induce other knee complications such as cartilage 
damage and meniscus tears, and eventually, osteoarthritis development. Tendon 
auto- or allografts are the current treatment standard to replace the torn ACL and 
restore normal knee function. Despite the favorable outcomes of the current 
reconstruction strategy, many well-known limitations are also associated with it, 
such as graft availability, risk of immune rejection, and mis-matched 
biomechanical properties between the graft and the native ACL it is meant to 
replace. These limitations have motivated researchers to investigate the 
development of a tissue engineered graft that can overcome these limitations 
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CHAPTER 3  
Scaffold-Less Tissue Engineered Bone-Ligament-Bone Constructs 
 
 
Tissue engineering provides opportunities for a paradigm shift in the 
treatment of a torn ACL. For the past decades, investigators have attempted to 
find tissue engineered ACL grafts with biomechanical properties similar to the 
native ACL. Current tissue engineering methodologies utilize various 
biocompatible scaffolds, fibroblast or mesenchymal stem cells, and growth 
factors that promote cell proliferation and differentiation to engineer grafts in vitro. 
While tissue engineered scaffolds have many advantages, limitations such as 
undesirable degradation rates of the scaffolds, immediate cell death after 
implantation, and mis-matched biomechanical properties hinder their ability to 
develop into a mature tissue that can replace the native ACL.  
 
For these reasons, we have developed a compliant, scaffold-less tissue 
engineered construct using bone marrow stromal cells. The efficacy of this 
scaffold-less cell-based approach was demonstrated via morphological and 
mechanical analyses using a bone-ligament-bone construct (BLB) in a rat medial 
collateral ligament replacement. The approach was then used to replace the ACL 
in a sheep model. After two months of in vivo recovery, a functional enthesis was 
generated between the tissue engineered construct and the native tissue. 
Vascularization and innervation development were found as early as three 
months in vivo. By six months of in vivo recovery, the morphology of collagen 
and collagen fascicles matched the native ACL longitudinally and cross-
sectionally. By nine months of in vivo recovery, the morphological properties and 
biomechanical properties (to be discussed in Chapter 4) were superior to those 
of the patellar tendon autograft, the commonly used tendon graft for ACL repair. 
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These results suggest that this scaffold-less tissue engineering technique is 
promising for ACL repair. 
3.1 Current trends in tissue engineering 
Current tissue engineering approaches utilize (1) scaffolds that promote 
tissue regeneration, (2) isolated cells that continuously proliferate and 
differentiate in vitro, (3) growth factors that facilitate in vitro or in vivo tissue 
regeneration, or (4) combinations of the elements enumerated above [1-6]. The 
incorporation of growth factors has been used to enhance cell migration, 
proliferation, and collagen deposition in ACL repair. Issues currently hindering 
clinical use of engineered tendons and ligaments include mechanical properties 
of the engineered graft that shield cells and inhibit neoligamentous tissue growth, 
challenges associated with integration between host bone and newly developed 
tissue and a rapid rate of scaffold degradation in vivo with a corresponding rate 
of tissue regeneration that is too slow [7].  
3.1.1 Scaffold 
Current tissue engineering approaches usually involve seeding cells onto 
natural or synthetic scaffolds that are both biocompatible and biodegradable [4]. 
Ideally, scaffolds should be capable of: (1) bridging complex three-dimensional 
(3D) anatomical defects; (2) facilitating tissue regeneration by promoting 
embedded cell adhesion, migration, and proliferation; (3) providing temporary 
mechanical support until the generation of the neotissue reaches a self-
sustaining state; and (4) biodegrading with a degradation rate compatible with 
the rate of the neotissue formation [2]. Typically the scaffold, initially mimicking 
the structural and mechanical properties of the ACL, gradually degrades and 
transfers the mechanical loads to the new tissue regenerated within the scaffold. 
The current paradigm is to match or exceed native ligament stiffness and 
strength in order to restore stability to the knee [8]. Both biological and synthetic 
materials have been investigated as potential scaffold materials for tissue-
engineered knee ligament repair, including collagen, silk, biodegradable 
polymers and composite materials, all with limited success [3, 8]. Knitting, 
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braiding, and electrospinning are popular techniques used in the manufacture of 
biocompatible fibrous scaffolds for ligament tissue engineering. Biological 
materials used in tissue engineering ligament are the common biological 
components of the extracellular matrix such as collagens and proteoglycans. 
Biologically derived materials naturally contain information that facilitates cell 
attachment and function and it is believed that these signals from biologically 
derived extracellular matrix materials may continue to provide stimuli to provide 
guidance to tissue remodeling [9]. Synthetic materials are easy to fabricate and 
store. They also have good mechanical strength. Therefore, a combination of the 
two may provide the most optimal solution by synergizing the advantages from 
both types of materials [10].   
 
Dunn et al., 1992 fabricated an ACL graft by embedding aligned cross-
linked collagen fibers in collagen matrix. The graft was used to replace the ACL 
in a rabbit model. The study demonstrated neotissue formation after 20 weeks 
post-operation (PO). The resorbable scaffold initially weakened (4 weeks PO). 
The scaffold gained a higher ultimate tensile strength at 20 weeks PO compared 
to the 4 weeks PO and the initial ultimate tensile strength prior to surgery 
because of the ingrowth and remodeling of neotissue at 20 weeks PO [10]. The 
authors concluded that the composite graft encouraged the development of 
functional neoligament tissue [10]. Cavallaro et al., 1994 extracted type I collagen 
from bovine tendons and used a collagen threadmaking apparatus to fabricate 
the collagen threads [9]. The apparatus extruded the collagen into a buffered 
solution of polyethylene glycol, followed by rinsing and air-drying. The threads 
were crosslinked and knitted to form a collagen fabric that provided a highly 
ordered structure with high ultimate tensile strength. The collagen fabric was then 
used to replace the ACL in a dog model. The TEM analysis showed that the 
neoligament in the mid-substance of the graft at 12 weeks PO was not as well 
organized as the native tissue, but the fibril diameter distribution pattern of the 
graft was found to be similar to that of the native ACL. No mechanical analysis 
was reported in this study and thus made it difficult to evaluate the mechanical 
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properties of the grafts [9]. Altman et al., 2002 developed a twisted fibrous silk 
matrix that consisted of bundles of silk fibers [11]. Their in vitro work has shown 
that the silk scaffold promotes cell proliferation and its mechanical properties, 
including ultimate load to failure, geometric stiffness, and elongation to failure, 
are similar to those of the native ACL [11]. Li et al., 2007 designed an 
electrospun scaffold fabrication method to fabricate an anisotropic biodegradable 
nanofibrous scaffold, composed of poly-ε-capeolaxrone, for tissue engineering 
applications. The anisotropy and mechanical properties such as Young’s 
modulus, yield strain, and stress can be controlled in this method [12]. Freeman 
et al., 2011 has investigated combining a novel poly L-lactic acid (PLLA) fibrous 
scaffold with a poly diacrylate PLLA hydrogel for ACL tissue engineering in vitro. 
The PLLA fibrous scaffold graft provided a similar stress-strain response as that 
of the native ACL. Hydrogel absorbs water and releases it during stretch. 
Therefore, the addition of the hydrogel enhanced the viscoelasticity of the graft 
[13]. Cooper et al., 2007 developed synthetic braided PLLA scaffolds seeded 
with primary rabbit ACL cells as grafts for ACL repair in a rabbit model [14]. At 
12-weeks PO, histological analysis demonstrated tissue healing and 
regeneration in the graft. The biomechanical degradation of the cell-seeded 
scaffold was not dramatically different from that of the control graft [14]. The 
tissue engineered approaches described above attempted to match the 
biomechanical properties of the native ACL by combining multiple synthetic 
structures and varying physical properties of these structures (e.g., density, 
braiding pattern and the number of crosslinks between fibers). However, 
unfavorable biomechanical degradation and instability occurs. The integration of 
the graft with native bone was not evident in most of these studies. Spalazzi et 
al., 2006 proposed a triphasic scaffold that consisted of three distinct but 
continuous regions to mimic the native ligament to bone insertion --ligament, 
ligament-bone interface, and bone. Phase 1 of the scaffold was made of 
polyglactin knitted mesh sheets; phase 2 was made of poly (D-L-lactide-co-
glycolide) copolymer (PLGA) microspheres; phase 3 was made of composite 
microspheres consisting of PLGA and bioactive glass [18]. The scaffold was tri-
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cultured with fibroblasts, chondrocytes, and osteoblasts and used as an ACL 
graft in a rat model. 8 weeks after in vivo recovery, the scaffold demonstrated 
that it facilitated multilineage cellular interactions, tissue infiltration, and abundant 
matrix production, thus presenting itself as a potential for regenerating the 
interface between soft tissue grafts and bone in tissue engineering ACL grafts 
[19]. The co-cultured scaffold degraded over time in vivo with a significantly 
decreased compressive modulus measured at 8 weeks PO as compared to the 
modulus obtained in vitro. The scaffold did however maintain the structural 
integrity required for endogenous tissue growth.  
 
The use of acellularized tissue as ACL grafts has also become popular 
because of its advantages such as biomechanical stability, biocompatibility and 
improved ability for cellular repopulation and remodeling [15-17]. In vitro studies 
showed good biomechanical properties of the tendon allograft [15, 16]. However, 
in vivo results are more relevant to evaluating the efficacy of the graft. This 
source of this rationale is that only analyses from in vivo results demonstrate the 
long-term characteristics of the grafts such as the neotissue development and 
enthesis formation between the graft and native bone. Tischer et al., 2010 used 
acellularized semitendinosus tendon allografts with autologous fibroblasts and 
replaced the ACL in a rabbit model. The study demonstrated the overall inferior 
biomechanical properties of these cell seeded tendon allografts after 8 weeks 
PO. The geometric stiffness of these tendon allografts only attained 20% of that 
of the native ACL. The authors concluded that graft design modifications, such as 
acellularization process, must be performed in further studies to yield better in 
vivo results [17].   
 
In conclusion, while scaffolding strategies appear to promote fibroblastic 
or osteogenic cell growth, undesirable characteristics such as a tendency to 
rupture, loss of stiffness and strength in vivo, immune rejection, improper scaffold 
degradation rates, and weak implant/native tissue interfaces have eliminated 
many scaffold-based tissue engineered ligament approaches from further 
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consideration [20]. The mechanical property requirements of engineered 
ligament at the time of replacement remain under debate [3, 8, 21]. The 
discussed tissue engineered scaffolds usually have higher material properties at 
the time of implantation. Recent evidence suggests that stiff scaffolds shield the 
cells within these structures from strains required for proper signal induction and 
hence, growth of neoligamentous tissue [3, 8, 20]. The result is loss of viability 
with time in vivo and increased joint laxity [20, 21]. Moreover, the stresses during 
normal anterior cruciate ligament (ACL) function do not typically exceed 20% of 
ACL strength [21], suggesting that current engineering approaches over-design 
for strength, especially if eventual collagen growth and remodeling are expected 
with time. The biomechanical mis-match and dissimilar tissue interface between 
native bone and engineered ligament are other existing design issues that may 
impede clinical applications [7, 22]. 
 
3.1.2 Cells 
Ligament is composed of both fibroblasts and the extracellular matrix 
secreted by the fibroblasts. Attempts to mimic this environment by depositing 
cells onto scaffolds for tissue engineering applications has lead to contradictory 
results in previous studies by others in the field. While Tischer et al., 2010 
showed a decrease in the biomechanical properties of scaffolds embedded with 
autologous fibroblasts 8 weeks PO [17], other studies showed that scaffolds 
embedded with fibroblasts or mesenchymal stem cells (MSCs) have greatly 
enhanced in vivo performances as compared to unseeded scaffolds, as 
previously described in Cooper et al., 2007 [14]. The optimal cell source for 
ligament tissue engineering is still under investigation. The variation in the 
behavior of cells from different cell sources, passage numbers, and the animal 
models all contribute to the consideration of cell selection [2]. Current cell-based 
tissue engineering approaches for ligament and tendon repair include primary 
fibroblasts derived from ligaments and tendons such as the ACL, medial 
collateral ligament (MCL), patellar tendon or Achilles tendon [23] or MSCs 
isolated from bone marrow stromal cells (BMSC) [24].  
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Given the proper environment, BMSCs can differentiate into many types of 
mesenchymal lineages including bone, ligament, tendon, cartilage, muscle, nerve 
and fat [25, 26]. BMSCs have demonstrated advantages over differentiated cells 
such as ACL fibroblasts that may render them optimal for ligament engineering, 
and their potential for tissue regeneration is the subject of ongoing investigations. 
BMSCs are capable of self-renewal and have more differentiation potential than 
fibroblasts originating from the ligament or tendon. Moreover, the proliferation 
system of BMSCs is robust and their adaptability to local environments (e.g. in 
vitro investigation) is strong [3, 27]. BMSCs create an environment that 
diminishes immune response and enhances regeneration. Thus the potential to 
use allogenic sources rather than autogenic sources of BMSC exists [28]. 
BMSCs can be isolated from autologous sources and may be expanded in 
culture while maintaining their multipotency which makes them an attractive 
candidate for tissue engineering [25, 28-32]. BMSCs also secrete bioactive 
factors that inhibit scarring and apoptosis and stimulate angiogenesis [28]. 
BMSCs are an accessible and biocompatible source of cells that are 
immunosuppressive, especially for T-cells [28], making both autogenic and 
allogenic sources good candidates for use in regenerative medicine. 
 
Hairfield-Stein et al., 2007 used porcine BMSCs to generate self-
organized rod-like tissues with silk suture segments as anchor points in a 14-day 
culturing period [33]. Fan et al., 2009 seeded MSC derived from bone marrow 
onto micro-porous silk scaffolds. Their in vitro study indicated that MSCs 
proliferated and differentiated into fibroblast-like cells. The cell-seeded graft was 
then used to replace the ACL in a pig model. After 24 weeks PO, the MSCs in 
the graft exhibited a fibroblast morphology. The scaffold survived in vivo 24 
weeks PO with a significant amount of scaffold degradation. The enthesis zones 
were observed in these remodeled grafts [24].     
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3.1.3 Growth factors 
Previous studies have shown the requirements for driving BMSCs to bone 
in vitro are ascorbic acid, dexamethasone (DEX), TGF-b, FGF-b, and an organic 
phosphate [34-40].  In contrast, BMSCs cultured in TGF-b, FGFb, and ascorbic 
acid in the absence of DEX can be driven to a ligament lineage [40-42].  In recent 
years, platelet-rich plasma (PRP) therapy has started to spread into many clinical 
applications including ACL repair. The method collects and concentrates 
autologous platelets to activate and release high concentration of the growth 
factors such as PDGF, TGF-beta, VEGF, FGF and EGF. Because of large 
amounts of growth factors it contains, the method has been used to stimulate 
tissue growth and regeneration clinically [43, 44]. Ascorbic acid is essential for 
hydroxyproline formation. Without hydroxyproline, the collagen triple helix cannot 
maintain its 3D conformation [72].   
 
3.1.4 Morphological characterization methods of tissue engineered 
ligaments 
Since a single specific marker does not exist for either bone or ligament, 
characterization of tissue types engineered from MSCs involves morphological 
observations of cellular and ECM structures and the presence of the expected 
cell biomarkers generally found in neonatal bone and ligament. For bone, the 
presence of alkaline phosphatase, an enzyme that cleaves phosphate ions from 
organic molecules, is a precursor to mineralization and thus an early sign of bone 
formation [45]. Type I collagen mineralized with hydroxyapatite crystals, the 
presence of osteocalcin, and the absence of type II collagen, the predominant 
protein of cartilage, are also used as markers of a bone lineage and have been 
shown to be characteristics of in vitro EBC from BMSCs [40]. In addition, RUNX2 
is used to visualize pre-osteoblasts in the periosteum, osteoblasts and 
osteocytes in the bone, while CD31 is used to visualize the blood supply in the 
bone [46, 47]. Ligament lineage is characterized by type I collagen, the lack of 




There are many advantages to current tissue engineering strategies with 
scaffolds including immediate stability [3, 48]. However, cellular stress-shielding 
can limit the ability of the cells within the scaffold to develop and replace the 
native ACL. In addition, the region of the graft or engineered material within the 
bone tunnel may not fully integrate with native tissue [49]. The initial response of 
the body to either grafts or current tissue engineering approaches results in 
reduced stiffness of the replacement [50]. The biomechanical mismatch and 
dissimilar tissue interface between native bone and engineered ligament are 
additional existing design limitations that may impede translation to clinical 
applications [7, 22].  
 
Recently, our laboratory has successfully fabricated engineered ligament 
constructs (ELC) and engineered bone constructs (EBC), using these specific 
growth factors on BMSCs during proliferation and differentiation in vitro [40]. 
Furthermore, co-culturing these two types of constructs enabled us to generate 
3D bone-ligament-bone (BLB) constructs with viable entheses in vitro. The use of 
the engineered BLB as a medial collateral ligament (MCL) or an ACL is 
discussed in the following sections.  
 
3.2 Creation of a bone-ligament-bone (BLB) construct and its use as a 
medial collateral ligament (MCL) replacement 
Because of the limitations current tissue engineering researchers are 
facing utilizing scaffolds, our laboratory has developed a compliant, co-cultured, 
and scaffold-less tissue engineered construct. In this approach, isolated bone 
marrow stromal cells (BMSC) are differentiated along osteogenic and fibrogenic 
pathways and in doing so, generate their own extra-cellular matrices. Cell 
contraction within the matrix leads to the formation of three dimensional 
constructs without artificial scaffolds. The engineered construct forms viable 
bone-ligament interfaces in vitro. Its efficacy as a ligament graft was 
demonstrated when used as an MCL replacement in the rat. The implanted BLB 
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not only possessed a large amount of viable cells, but also developed vascular 
and neural systems.  
 
3.2.1 In vitro co-culture of BLB constructs 
3.2.1.1 Preparation of solutions and media 
Unless otherwise indicated, all solutions and media were prepared and 
stored at 4°C prior to the isolation and culture of cells and warmed to 37°C in a 
heated water bath immediately prior to use. The media, with slight modifications 
from [51, 52], were as follows: for ligament, growth medium (GM) consisted of 
400 ml of Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Rockville, MD, 
Cat# 10565-042) with 100 ml Fetal Bovine Serum (FBS; Gibco, Rockville, MD, 
Cat# 10437-028), 6 µg/ml fibroblast growth factor basic (FGFb; Peprotech, Rocky 
Hill, NJ, Cat# 100-18B), 0.13 mg/ml asc-2-phos (Sigma, St. Louis, MO, Cat# 
A8960-5G), 0.05 mg/ml L-proline (Sigma, St. Louis, MO, Cat# P5607-25G), 5 ml 
antibiotic-antimycotic (Sigma, St. Louis, MO, Cat# A9909 ) and differentiation 
medium (DM) consisted of 460 ml DMEM with 35 ml 100% Horse Serum Albumin 
(HSA, Gibco,  Rockville, MD, Cat# 16050-122), 0.13 mg/ml asc-2-phos,  0.05 
mg/ml L-proline, 2 ng/ml transforming growth factor-beta (TGF-b; Peprotech, 
Rocky Hill, NJ, Cat# 100-21), and 5 ml antibiotic-antimycotic (Sigma, St. Louis, 
MO, Cat# A9909). For bone, the growth and differentiation media were the same 
as GM and DM, respectively, with the addition of 10-8 M dexamethasone (DEX; 
Sigma, St. Louis, MO, D4902-25MG).   
 
3.2.1.2 Preparation of Culture Dishes  
BLB constructs were engineered in individual 35 mm plates. Briefly, each 
35 mm plate was coated with 1.5 ml of Sylgard (Dow Chemical Corporation, 
Midland, MI, type 184 silicon elastomer) and allowed to cure for 3 weeks prior to 
use. Sylgard coated plates were then coated with laminin at 3.0 µg/cm2 per plate 
(30 µg of Natural Mouse Laminin (Gibco, Rockville, MD, Cat# 23017-015) and 3 
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ml of Dulbecco’s Phosphate-Buffered Saline (DPBS) pH 7.2 (Gibco, Rockville, 
MD, Cat# 14190-144) per plate) and dried for 48 h. Salt crystals were dissolved 
and removed by rinsing the plates with 3 ml DPBS. The plates were then filled 
with 2 ml of previously described GM, decontaminated with UV light (wavelength 
253.7 nm) for 90 minutes and placed in a 37°C, 5% CO2 incubator for 1 week 
prior to plating BMSC.  
 
3.2.1.3 Bone Marrow Stem Cell Isolation and Expansion  
Surgical procedures were performed to remove both femurs for the 
isolation of bone marrow stromal cells (BMSC). The marrow was flushed from the 
donor bone tissue using a syringe with an 18½-gage needle filled with GM. The 
marrow was further dissociated by mixing with a 21½-gage needle before being 
centrifuged at 480 g for 5 minutes at 25°C. The pellet was resuspended in 10 ml 
GM (as appropriate for constructs under construction, ligament versus bone) and 
plated into 100 mm diameter tissue culture dishes. The dishes were kept in an 
incubator at 37 °C, 95% humidity, and 5% CO2. After 48 h, the non-adherent 
cells were removed by rinsing with DPBS. The adherent BMSC were cultured to 
80% confluence, at which time the cells were enzymatically removed from the 
100 mm plates using a 0.25% trypsin-EDTA solution (Gibco, Rockville, MD, Cat# 
25200-072) and passaged. Cells were plated onto prepared culture dishes within 
the third and fifth passages.  
 
3.2.1.4 Preparation of Self-Organized Bone Constructs  
After pre-incubation, the GM was aspirated and 2 * 105 cells per 35 mm 
dish were seeded onto each laminin-coated Sylgard plate, after which the bone 
GM was changed at 2–3 days. After approximately 3 days, when the cells 
became confluent, bone DM was substituted to induce construct formation. The 




3.2.1.5 Bone-Ligament-Bone Construct Formation  
The GM was aspirated from additional laminin-coated Sylgard plates and 
2 ml of the ligament cell suspension containing 2 * 105 cells/ml-GM were plated 
in each 35 mm culture dish. The plates were maintained in a 37°C, 5% CO2 
incubator and the ligament GM was changed at 2-3 days. After the cells became 
confluent, approximately 3 days later, engineered bones (fabricated as described 
above) were cut into two segments and each segment was pinned using two 
minutien pins on top of the ligament cell monolayer such that the proximal bone 
construct ends were 10 mm apart. Following bone pinning, GM was replaced 
with ligament DM and this ligament DM was changed every 2-3 days. 
Approximately 1 week following the introduction of DM, the ligament monolayer 
rolled up around the bone construct forming a 3D BLB construct with a total 
length of 15 mm (Figure 3.1A). All constructs were held in culture and fed fresh 
DM every 2-3 days for one week, at which point 6 constructs were used for 
medial collateral ligament (MCL) one-month replacement and 3 constructs were 
used for two-month replacement.  The remaining constructs were held in culture 
an additional 4 weeks to serve as time matched controls for the in vivo studies.  
Of these 6 one-month explanted constructs, 2 were prepared for histological 
analysis and 4 for cyclic tension tests. All 3 two-month explanted constructs were 
prepared for histological analysis. 
 
Figure 3.1 Fabrication, implantation, and explantation of 3D Bone-Ligament-Bone (BLB) 
constructs engineered in vitro for Medial Collateral Ligament Replacement. (A) BLB 
construct just prior to implantation; approximately 3 days after detachment of the 
monolayer, the cells self organized into a cylinder. Total length of the construct pin to pin 
= 15 mm; diameter = 0.47 mm. (B) 3D BLB from image (A) placed inside silicone tubing and 
secured in replacement of excised MCL; (C) 3D BLB construct four weeks following 
implantation. The presence of the silicone tubing makes it easy to visualize and excise the 
implanted construct; following one month of implantation, the engineered BLB has fused 
with the bone at the femur and tibia and increased in diameter to 0.53 mm. (D) 3D BLB 
excised from bone to be used for histology [53]. 
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3.2.2 In vivo BLB construct implantation as an MCL replacement in rat 
3.2.2.1 Animal Model and Animal Care  
Female Fischer 344 rats obtained from the Charles River Laboratories, 
Inc. (Wilmington, MA) were used. All animals were acclimated to our colony 
conditions, i.e., light cycle and temperature, for 1 week prior to any procedure. 
Rats were housed in hanging plastic cages (28 × 56 cm) and maintained on a 
12h/12h light/dark cycle at a temperature of 20-22°C. The animals were fed 
Purina Rodent Chow 5001 laboratory chow and were given free access to water. 
All surgical procedures were performed in an aseptic environment with animals in 
a deep plane of anesthesia induced by i.p. injections of sodium pentobarbital (50 
mg/kg). Supplemental doses of pentobarbital were administered as required to 
maintain an adequate depth of anesthesia. Following any surgical procedure, the 
animals were singly housed until the date of explantation. All animal care and 
animal surgeries were in accordance with The Guide for Care and Use of 
Laboratory Animals (Public Health Service, 1996, NIH Publication No. 85-23); the 
experimental protocol was approved by the University Committee for the Use and 
Care of Animals.   
 
3.2.2.2 MCL Replacement via Engineered BLB Constructs  
Six BLB constructs fabricated from the isolated BMSCs were used as 
MCL replacements in host rats (Figure 3.1B-D). The rat MCL replacement model 
was used because the size of the adult native rat MCL (12 mm x 3 mm) is 
approximately the same as that of our engineered BLB construct (15 mm x 0.47 
mm).  Additionally, the MCL is superficial, providing easy access to bone at the 
femur and the tibia, thus simplifying both the replacement of ligament and the 
recovery from the surgical procedures. Briefly, the distal medial head of the 
femur and proximal medial head of the tibia were exposed. The muscle and 
connective tissue surrounding the MCL were reflected exposing the MCL, which 
was severed from its points of insertions on both the femur and tibia. The native 
MCL was preserved for subsequent analysis of structure and function. A Dremel 
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drill was used to drill 0.9 mm holes at the points of MCL insertion on the femur 
and tibia. A portion of the ligament region of the engineered BLB construct was 
surrounded by a 1.6 mm ID diameter silicone tube for subsequent identification 
during explantation (Figure 3.1B), and the bone sections of the construct were 
inserted into the drill holes. The constructs were secured to the bone by suturing 
them to the surrounding connective tissue. Finally, the muscle layers were closed 
using 7-0 suture and the skin was closed using 4-0 suture. Within one hour, 
animals were awake and resumed normal cage activities of eating and drinking. 
All animals were allowed to recover for either one or 2 months before removal of 
the BLB explants. Prior to surgery and following the recovery period and prior to 
construct explantation, all animals were assessed for locomotor function using 
foot print analysis and rotorod testing [54]. Either one or two months following the 
explantation, the entire knee was extracted from the animal (Figure 3.1C), the 
engineered construct was isolated from surrounding tissues, and the patellar 
tendon, ACL, posterior cruciate ligament, and lateral collateral ligament were 
excised leaving the BLB-based MCL replacement tissue adhered to the femur 
and tibia (Figure 3.1D).  The explanted BLB constructs were either fixed for 
histochemical analysis or briefly placed in transfer media (DPBS with 2% 
antibiotics) prior to mechanical testing. 
 
3.2.2.3 Native MCL Dissections 
Pregnant Fischer 344 rats were obtained at 13 days into the gestation and 
acclimated under the same conditions as previously described. Fourteen days 
following the birth of the pups rats were euthanized with an overdose of sodium 
pentobarbital (100 mg/kg) administered by intraperitoneal injection. The legs 
were dissected, removing the skin and muscle but maintaining the ligament 
connections at the knee. The MCL (n=5) was isolated by removing all other knee 
ligaments. The tibia and femur were cut mid-bone to provide tissue for gripping 




3.2.3 Morphological analysis of the BLB in vitro, BLB explant, and native 
MCLs 
Histochemical and immunofluorescent staining was conducted to obtain 
the cell availability, the morphology of extracellular matrix, vascularization, and 
innervation of the BLB in vitro, BLB explant, and native MCLs. These samples 
were placed into TBS medium, frozen in cold isopentane and stored at -800C 
until needed. 
 
For histochemical staining, three to five samples per group of 3D BLB 
constructs developed in vitro and after implantation in vivo and native MCLs were 
analyzed. Samples were sliced longitudinally with a cryostat at a thickness of 
approximately 12 µm, adhered to Superfrost Plus microscopy slides and used for 
staining. Sections were stained for general morphology observations with 
hematoxylin and eosin (H&E).  
 
Immunofluorescent staining with specific antibodies was performed to 
detect the presence of blood vessels (CD-31), collagen type I and elastin.  
Frozen sections were fixed with ice cold methanol for 10 min and rinsed 3 times 
with Phosphate Buffered Saline (PBS).  Sections were blocked for 30 min with 
PBS-0.05%Tween20 (PBST) containing 20% calf serum (PBST-S) at room 
temperature.  Sections were incubated overnight at 40C with the primary 
antibodies in PBST-S.  The concentration of each of the primary antibodies was 
as follows: 10 mg/ml of rabbit anti-rat collagen type 1 (Abcam), 10 mg/ml of rabbit 
anti-rat elastin (Chemicon) and 20 mg/ml of mouse anti-rat CD31 (AbD Serotec, 
Oxford, UK). One hour room temperature incubation with Cy3-conjugated anti-
mouse or anti-rabbit antibody (Jackson ImmunoResearch Lab., West Grove, PA) 
was used for visualization.  Co-staining of sections with fluorescein labeled wheat 
germ agglutinin (WGA; 5 mg/ml; Molecular Probes, Eugene, OR) was used for 
general visualization of the sample structure. Nuclei were stained by 5 min 
incubation with a DAPI solution (Sigma, St. Louis, MO) in PBST. The sections 
were examined and photographed with a Leica microscope.  
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3.2.3.1 Morphology of 3D BLB constructs in vitro 
Prior to utilization for implantation, histological analysis of the BLB 
constructs with H&E showed the presence of areas resembling bone at both 
ends of the constructs (Figure 3.2A). The fibrous middle part of the BLB 
constructs resembled ligament (Figure 3.2A). At the higher magnification the type 
I collagen stained bone portion showed dense deposits of collagen (Figure 3.2B 
and D) similar to those found in the developing bone in vivo. Type I collagen 
immunostaining of the ligament portion of the BLB construct revealed well 
aligned longitudinally oriented collagen fibers, some evidence of crimp 
morphology and elongated nuclei between fibers (Figure 3.2C and E). The 
middle part of the BLB constructs also stained positive for elastin (Figure 3.2F). 
The ligament portions of the 3D BLB constructs self-assemble in vitro around 
previously formed engineered bone constructs (EBCs). The absence of DEX in 
the ligament media produces unmineralized ECM that displays evidence of the 
characteristic crimp morphology of type I collagen fibrils in vitro. The ligament 
region development in vivo includes increased type I collagen content, improved 
collagen organization and more consistent crimp morphology and the 
development of a continuous, aligned elastin network.   
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Figure 3.2 Histological evaluation of the 3D BLB construct developed in vitro. (A): H&E 
staining. (B) and (D): collagen 1 immunostaining (red) of the end of the construct. (C) and 
(E): collagen 1 (red) immunostaining of the middle part of the construct. (F): elastin 
immunostaining (red) of the middle part of the construct. DAPI staining (blue) was used to 
visualize the nuclei [53]. 
 
3.2.3.2 Morphology of 3D BLB explants  
During either one or two months of implantation, the BLB constructs 
replaced the MCL in the left leg of the host rat model. Both one- and two-month 
explants were comparable in structure, with 2-month explants showing slightly 
more advanced structural features. Therefore, only the 2-month explants data 
are shown. When explanted, the constructs were integrated well into the native 
bone at both the tibial and femoral sites (Figure 3.3) and were supplied by the 
blood vessels generated from the host animal. Longitudinal sections of the 
middle of BLB explants were stained with H&E (Figure 3.4).  Collagen fibers filled 
the entire middle part of the explant with more cellular areas located at the 
periphery (Figure 3.4A-C). While the collagen fibers in the explants were highly 
organized and resembled that of native adult rat MCL (Figure 3.4E), the explants 
displayed a higher nuclei per collagen fiber ratio placing them between neonatal 
(Figure 3.4D) and adult (Figure 3.4E) MCL.  
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Figure 3.3 H&E staining of areas of native bone/ 3D BLB construct interfaces at the tibia 
(A-B) and femur (C-D) sides after 2 months of implantation [53].   
 
Figure 3.4 H&E staining of the middle part of the 3D BLB construct after 2 months of 
implantation (A-C) and native MCL ligament from 21 day old neonatal (D) and from adult 
(E) rat [53].   
Immunostaining of the middle of the BLB explants for type I collagen 
(Figure 3.5A and B) showed patterns of more densely packed collagen fibers 
than those found in neonatal MCL (Figure 3.5C) and more closely  resembled  
type I collagen staining of adult rat MCL (Figure 3.5D). Blood vessels were easily 
detected at the periphery of the middle part of the BLB explants (Figure 3.6A and 
B). The degree of vascularization was slightly higher than that found in the native 
neonatal (Figure 3.6C) and adult (Figure 3.6D) rat MCL. The elastin 
immunostaining of the middle of the BLB explants detected very thin 
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longitudinally oriented elastic fibers (Figure 3.7A). The elastin content was higher 
than that found in the 3D BLB constructs in vitro but lower than in the native 
neonatal (Figure 3.7C) and adult (Figure 3.7E) rat MCL. 
 
Figure 3.5 Immunostaining of the middle part of 3D BLB construct after 2 months of 
implantation (A and B) and native MCL ligament from 21 day old neonatal (C) and from 
adult (D) rat with antibodies against collagen 1 (red). DAPI staining (blue) was used to 
visualize the nuclei [53]. 
 
Figure 3.6 Immunostaining of the middle part of 3D BLB construct after 2 months of 
implantation (A and B) and native MCL ligament from 7 day old neonatal (C) and from adult 
(D) rat with antibodies against CD31 (red) to visualize blood vessels. DAPI staining (blue) 
was used to visualize the nuclei. WGA lectin-fluorescein (green) was used to visualize the 
general tissue structure [53] 
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Figure 3.7 Immunostaining of the middle part of 3D BLB construct after 2 months of 
implantation (A) and native MCL ligament from 7 day old neonatal (C) and adult (E) rat with 
antibodies against elastin (red). DAPI staining (blue) was used to visualize the nuclei. WGA 
lectin-fluorescein (green in B, D and F) was used to visualize the general tissue structure 
in 3D BLB construct (B), 7-day old neonatal (D) and adult (F) rat [53]. 
3.2.4 Summary of engineered BLBs used as MCL replacements 
The present approach avoids the use of a resorbable scaffold and adopts 
a design rubric based on the concept of displacement or strain controlled rather 
than load (or stress) controlled mechanical requirements of knee ligaments. The 
mechanics on the engineered BLBs used rat MCL replacements will be 
discussed in detailed in Chapter 4. After either one or two months in vivo as a 
replacement for the medial collateral ligament (MCL) of a rat, the bone portion of 
3D BLB constructs integrated well with the native bone. The ligament region of 
the rat 3D BLB constructs showed the presence of aligned, crimped, type 1 
collagen and elastin. The regenerated extracellular matrix on these engineered 
BLB explant demonstrated its great potential of use as a ligament graft.  
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3.3 BLB constructs used as ACL grafts in sheep model 
The successful outcome of the engineered BLB used as MCL replacement 
in rat demonstrated the efficacy of this scaffold-less co-cultured technique and 
also suggested its great potential as an ACL graft. For ACL replacement studies, 
a rat model is not ideal because its knee joint is small. The sheep and goat have 
commonly been chosen as large animal models for the knee [55-58] because of 
anatomical [59-62] and mechanical [63-66] similarities to human ACLs. We 
therefore scaled the geometry of the tissue engineered BLB up to match the size 
of a sheep ACL, then studied its use as an ACL replacement in the sheep model. 
We first characterized the morphological and mechanical properties of BLB 
explants after 2, 3, 4 and 6 months (Study 1). The purpose of this study was to 
engineer a 3D multi-phasic ligament model or BLB construct that will rapidly grow 
and remodel in vivo to attain biomechanical properties of native ACL. Preliminary 
results showed well organized extracellular matrix in BLB explants after 6 months 
in vivo. We then conducted a 9-month in vivo study using the BLB as an ACL 
graft with a patellar tendon autograft, as a surgical control (Study 2). The purpose 
of Study 2 was to compare the tissue engineered construct to a commonly used 
graft, the patellar tendon, physically, functionally and morphologically. To 
understand which cells determine the development of the engineered construct 
site, we used male bone marrow stromal cells to track (PCR) cell migration in 
female sheep. 
3.3.1 In vitro co-culture of the bone-ligament-bone (BLB) construct 
3.3.1.1 Preparation of solutions and media 
The solutions and media used to create sheep BLB constructs are the 
same as the ones used for rat BLB constructs. Please refer to section 3.2.1.1 for 
a detailed description.  
3.3.1.2 Preparation of culture dishes 
Cell culture plates (100 mm in diameter) were used to culture ligament 
cells and 35mm cell culture plates were used to culture bone cells. A portion of 
100 mm cell culture plates was coated with 12.0 ml of Sylgard for use of securing 
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3D constructs. These sylgard coated dishes were allowed to cure for 3 weeks 
prior to use. Plates were then filled with 20 ml of DPBS, decontaminated with UV 
light (wavelength 253.7 nm) for 90 minutes, and placed in a 37°C 5% CO2 
incubator for 1 week prior to use. 
3.3.1.3 Sheep BMSCs isolation and expansion 
BMSCs were collected from adult female black suffolk sheep and male 
lambs for different study purposes. Adult sheep were euthanized using 15mL of 
Fatal Plus (Vortech Pharmaceuticals, Dearborn, MI) and lambs, 4mL. The 
marrow from a single femur was scooped using a spatula into a 50 ml conical 
filled with DMEM and 2% antibiotic antimycotic solution. BLBs used for Study 1 
(2,3,4 and 6 months implantation) were made from adult female sheep. BLBs 
used for Study 2 (9 months implantation) were made from male lambs. Briefly, 
the marrow was minced with scissors, vortexed and pelleted using centrifugation 
(AccuSpin FR; Beckman Coulter Inc., Fullerton, CA) at 2500 rpm for 10 minutes 
at 25ºC. The supernatant was aspirated and the cell pellet was resuspended and 
divided equally into three 100 mm diameter tissue culture dishes for ligament 
differentiation and one 100 mm diameter dish for bone differentiation.  Each dish 
was fed with 8 ml GM. The bone dish was supplemented with DEX additionally 
(this held true for the rest of the BLB fabrication). The dishes were incubated at 
37ºC, 95% humidity, and 5% CO2. After 48 h, the non-adherent cells were 
removed by aspriating the old media and flushing the plates with DPBS three 
times. Then, all plates were fed with fresh GM. The adherent BMSC were 
cultured to 80% confluence, at which time cells were enzymatically removed from 
the 100 mm plate using a 0.25% trypsin-EDTA solution (Gibco) and passaged at 
a one to three ratio. Cells used to fabricate BLBs were from the third through fifth 
passages. 
3.3.1.4 Sheep BLB construct formation in vitro 
Self-organized bone constructs were engineered as previously described 
[Syed-Picard 2009]. Refer to 3.2.1.4 for a detailed fabrication description. Briefly, 
as shown in Figure 3.8, BMSCs were first isolated from sheep femurs (Step [1]). 
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Cells were proliferated and differentiated into osteoblast-like cells and fibroblast-
like cells using growth media and growth factors (Step [2]). The monolayers were 
carefully transferred from culture dishes to Sylgard coated dishes using sterilized 
tweezers. 2 x 105 bone cells were seeded in 1.5 mL GM onto 35 mm cell culture 
plates. DM was substituted for GM to induce construct formation. After 
approximately 2 days, a bone monolayer was formed on each dish. (Step [3]). 
Ligament monolayers were made in a similar fashion: 8 ml of the cell suspension 
containing 1.3 x 106 ligament cells was plated in each 100 mm culture dish. The 
dishes were placed in a 37ºC 5% CO2 incubator and the medium (GM) was 
changed every 2–3 days. After the cells became confluent, approximately three 
days later, a ligament monolayer had formed on each 100 mm culture dish. (Step 
[4]). The bone monolayers were transferred from the current culture dishes to 
Sylgard coated dishes with two minutien pins placed on the monolayers 
approximately 20 mm apart to guide the formation of 3-D bone constructs (Step 
[5]). The ligament monolayers were carefully transferred to Sylgard coated 100 
mm dishes. Two of the engineered bones previously described were pinned on 
top of a ligament monolayer, and in-line axially so that the inner ends were 30-40 
mm apart, to fabricate a 60-80 mm long BLB (Step [6]). At this point DM replaced 
GM for ligament. The individual BLB constructs had a diameter of 0.6 to 0.8 mm. 
Within one week of implantation eight of these constructs were pinned together 
laterally at their bone ends. Constructs fused together laterally to form a larger 
width construct with dimensions of approximately 60 to 80 mm long, 2.8 to 3.2 
mm in diameter (Step [7]). The BLB constructs did not develop a necrotic core 
during this period of time in vitro. The BLB constructs were then used for 
implantation as a sheep ACL replacement (Step [8]). 
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Figure 3.8 Fabrication process of a BLB construct in vitro. BMSCs were first isolated from 
sheep femurs (Step [1]). Cells were proliferated and differentiated into bone-like cells and 
ligament-like cells using growth media and growth factors (details can be found in the 
Methods Section (Step [2]).   Bone cells were seeded onto 35 mm cell culture plates. Cells 
became confluent and a bone monolayer was formed on each dish (Step [3]). Ligament 
cells were seeded onto 100mm cell culture plates. In the same fashion, cells became 
confluent and a large ligament monolayer was formed on each dish (Step [4]). The bone 
monolayers were transferred from the current culture dishes to Sylgard coated dishes with 
two minutien pins placed on the monolayers approximately 20 mm apart to guide the 
formation of 3-D bone constructs (Step [5]). The ligament monolayers were carefully 
transferred to Sylgard coated 100mm dishes. Two of the engineered bones previously 
described were pinned on top of a ligament monolayer, and in-line axially so that the inner 
ends were 30-40 mm apart, to fabricate a 60-80 mm long BLB (Step [6]). Within one week of 
implantation eight of these constructs were pinned together laterally at their bone ends. 
Constructs fused together laterally to form a larger width construct with dimensions of 
approximately 60 to 80 mm long, 2.8 to 3.2 mm in diameter (Step [7]). The BLB constructs 
did not develop a necrotic core during this period of time in vitro. The BLB constructs 
were then used for implantation as a sheep ACL replacement (Step [8]) [67]. 
3.3.2 In vivo sheep BLB construct used as ACL replacement  
3.3.2.1 Animal model and animal care 
Black Suffolk female sheep were used as hosts and BMSC donors for the 
fabricated BLB constructs. These sheep were obtained from the Michigan 
Livestock Exchange, various farms in the area or intra−university transfer. All 
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animals were acclimated to our Sheep Research Facility at the University of 
Michigan for one week prior to any procedure. Sheep were allowed to free range 
in the pasture until used for surgical implantation. The animals were given access 
to food and water ad libitum.  Femur and tibia bones were surgically dissected 
under aseptic conditions from the sheep immediately following euthanasia with 
Fatal Plus (Vortech Pharmaceuticals), to obtain bone marrow for BLB construct 
fabrication. The BLB constructs were implanted into the ACL site as a 
replacement tissue and the animals were allowed to recover for either two, three, 
four or six months before explantation. All surgical procedures were performed in 
an aseptic environment with anesthesia induced by i.v. injections of Ketamine 
and Diazepam and sustained with inhalation of halothane gas. After any surgical 
procedure, the animals were singly housed in secluded pens for two weeks and 
then released back into the herd until the date of explantation. All animal care 
and animal surgeries were in accordance with The Guide for Care and Use of 
Laboratory Animals (Public Health Service, 1996, NIH Publication No. 85-23); the 
experimental protocol was approved by the University Committee for the Use and 
Care of Animals. 
3.3.2.2 Sheep ACL replacement surgical techniques and procedure 
In study 1, ACL replacements were performed open. In study 2, ACL 
replacements were performed arthroscopically. 20 mls of Marcaine 1% with 
1:200,000 epinephrine had been injected in the knee for hemostasis. Two 6 mm 
incisions were made at the joint line on either side of the patellar tendon. The 
anterior cruciate ligament was identified and excised leaving a remnant of the 
ACL stump on both the femur and tibia to aid in positioning the ACL graft (Figure 
3.9 C-G). Drill guides were used to position guide pins in the center of the tibial 
and femoral footprints. Cannulated reamers were used over the guidewires to 
fashion 5-6 mm bone tunnels. The graft was passed through the bone tunnels 
with a suture attached to the proximal end of the graft. Minimal tension (<2 lbs) 
was applied to the graft as the proximal and distal ends were sutured to the 
periosteum with the knee in 30 degrees of flexion.  
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For Study 2, a 5mm diameter patellar tendon autograft (PTG) (Figure 3.9B) 
was used in a similar fashion using 7 mm femoral and tibial tunnels. 10 mm long 
bone plugs from patella and tibia were fashioned with an oscillating saw. A suture 
was attached to each end of the PTG for fixation. Approximately 5 lbs of tension 
was applied to the PTG as the proximal and distal ends were sutured to the 
periosteum with the knee in 30 degrees of flexion (Figure 3.9H). 
 
Figure 3.9 Arthroscopic ACL replacement in sheep utilizing BLB constructs and PT 
autografts. In vitro BLB construct prior to the surgery (A) has a total length of 70 mm 
including a 30 mm long ligament portion and two 20 mm long bone ends. A freshly 
harvested PTG (B) is about 11 cm long and 4-5 mm wide prior to the surgery. Both 
surgeries were done arthroscopically without utilizing interference screws for fixation (C). 
The landmarks of the ACL insertions on femur and tibia were located (D). Then the ACL 
was removed and the tunnels (E, F) were drilled through the insertion landmarks. The BLB 
construct (G) or PTG (I) was guided through the tibia and femur tunnels using the suture 
attached to the proximal ends of the grafts. 
 
During recovery, the animals were placed on a heat pad and covered with 
a blanket to maintain body temperature; respiration rate and other vital signs 
were monitored until the animal was standing. Once standing, the animal was 
moved to a pen and given access to food and water. Daily monitoring of the 
surgical site for infection was conducted. The sutures were removed at 14 days 
post surgery. 
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3.3.2.3 BLB explant, native ACLs, and patellar tendon dissections 
After two, three, four, six and nine months of implantation, BLBs, contralateral 
native ACLs, native patellar tendons and PT autografts (9-month) were dissected 
for morphological and mechanical analyses. Sheep were euthanized with Fatal 
Plus. The knees were dissected, removing the skin and muscle but maintaining 
the ligament connections at the knee. The patellar tendon with patella was first 
released from the patellofemoral groove and dissected to expose its tibial 
insertion. The patellar tendon with insertions intact was then removed from the 
knee and preserved for uniaxial tension tests. Then, the surrounding tissue was 
dissected, keeping the majority of the knee capsule intact. The tibia and femur 
were cut at mid-substance to provide substantial area to grip the specimen 
during mechanical testing. The knee specimen first underwent 45 degrees 
anterior drawer tests. The ACL, PT autograft and BLB were then isolated by 
removing all other knee ligaments and menisci. To visualize the deformation of 
the ACLs, PT autografts and BLBs, the medial condyle was carefully removed to 
reveal the entire tissue with insertion.  
 
3.3.3 Growth of BLB constructs and PT autografts during ACL 
replacement 
In Study 1, the dimensions of the ligament portion of the in vitro BLB 
constructs prior to implantation (N=7) were approximately 30-40 mm in intra-
articular length and 3.0±0.2 mm in diameter (7.1±1.0 mm2 in cross sectional area 
(CSA)). The BLB constructs we have designed are viscoelastic and they contain 
contractile cells. Prior to implantation they are longitudinally constrained and 
carry an internal tensile stress. At the time of insertion into the bone tunnel, they 
undergo viscoelastic deformation to restore this passive tension. The initial 
compliance of the intra-articular region of the BLB graft and its ability to maintain 
self-tension allow it to accommodate knee motion and not slip or develop slack. 
The sizes and structures of adult native ACL were compared to that of our BLB 
explants at the time of dissection at two-, three-, four- and six-month recovery 
time points (Figure 3.10A-E). The native ligaments (Figure 3.10F) were taken 
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from the contralateral knees of animals at the six-month recovery period time 
point. These results demonstrate that the BLB constructs rapidly grew physically 
in cross section during the initial implantation period and reached the size of 
native adult ACL at about four months after implantation.   
 
Figure 3.10 BLB construct in vitro (A) 30-40 mm in intra-articular length by 7.1±1.0 mm2 
CSA, [N=7]; BLB explant in vivo at (B) two: 17 mm long by 14 mm2 CSA [N=1], (C) three: 18 
mm long by 28 mm2 CSA [N=1] (D) four: 18 mm by 64 mm2 CSA [N=1] and (E) six months: 
16.3±1.1 mm long by 57.5±48.7 mm2 CSA [N=4]; native adult ACL: 18.5±0.8 mm long by 
27.7±4.3 mm2 CSA [N=3] (F) [67]. 
 
In Study 2, BLB constructs prior to implantation (N=7) were 30-40 mm in 
length, 3.0±0.2 mm in diameter, and 7.1±1.0 mm2 in cross sectional area (CSA). 
After 9 months in vivo recovery, the CSA of BLB explant (37.0±5.5 mm2) grew to 
the size of the contralateral ACL (N=14, 35.4±1.7 mm2). No significant 
differences were found between the BLB and the ACL CSA (p=0.81).  The CSA 
of the PTG prior to implantation was 18.9±1.0 mm2. After 9 months of recovery, 
the CSA of PTG CSA (N=7, 57.6±6.7 mm2) was significantly larger than that of 
the contralateral ACL (p<0.025). 
 
3.3.4 Morphological characterization of the sheep BLB in vitro, BLB 
explant, PT autograft, native ACL and PT 
 
Similarly to section 3.2.3, histochemical and immunofluorescent staining 
was conducted to obtain the cell viability, the morphology of extracellular matrix, 
vascularization, and innervation of the sheep BLBs in vitro, BLB explants, PT 
autografts, native ACLs and native PTs. Unless otherwise indicated, all sample 
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preparation and analysis were conducted following the same protocols 
developed previously and detailed can be found in section 3.2.3.  
 
In addition to detecting the type I collagen, elastin, blood vessels (CD-31) 
and innervation (NCAM), immunofluorescent staining with specific antibodies for 
lubricin was also performed on these samples to detect the presence of lubricin. 
The concentration of each of the primary antibodies was as follows: 10 µg/ml of 
rabbit anti-NCAM, rabbit anti-collagen type 1 and rabbit anti-elastin (all from 
Millipore); 10 µg/ml of rabbit anti-lubricin (Abcam,); and 10 µg/ml of rabbit anti-
CD31 (Abbiotec).  
3.3.4.1 Analysis of structure of in vitro sheep BLB prior to implantation 
Our previous studies have shown that the bone ends of the BLBs in vitro 
stain for mineralization activity (Alizarin Red). We have also shown the absence 
of markers for bone (Alizarin Red) and cartilage (type II collagen) in the mid-
section of the BLB constructs. The mid-sections stained for type I collagen 
indicating fibrogenic differentiation. Newly formed bone had areas of collagen-
rich matrix with cells trapped inside the matrix (arrow in Figure 3.11A and B). The 
mid-sections stained for type I collagen showed longitudinally oriented collagen 
fibers indicating fibrogenic differentiation (Figure 3.11C).   
 
Figure 3.11 Section of bone (A and B) and ligament (C) portions of BLB construct before 
implantation stained with antibody against collagen type 1 (red in A-C) and nuclear stain 




3.3.4.2 Analysis of structure, vascularization, and innervation of the BLB explant 
after 2, 3, 4 and 6 months in vivo recovery 
After 6 months of implantation in vivo, we compared cross sections at the 
centers of all BLB explants with those of the native ACL. Figure 3.12 shows H&E 
staining of cross sections through the centers of our BLB explants after 6 months 
in vivo (N=4). Figure 3.12A and 4B show the cross sections of the BLB explants 
fabricated using frozen BMSCs whereas Figure 3.12C and D show the cross 
sections of the BLB explants fabricated using fresh BMSCs. In constructs made 
from frozen cells (Figure 3.12A and B), the center of the section contained viable 
cells and was also highly vascularized (arrow in Figure 3.12A and B) suggesting 
the BLB was fully viable and actively remodeling and growing but that more time 
was needed in vivo to fully fill out the section with ligament tissue. In constructs 
made from fresh cells (Figure 3.12C), we see evidence of the initial fascicle 
formation. In Figure 3.12D (arrows) we see a fully remodeled BLB with collagen 
fascicle size and structure that very closely resembles that seen in adult native 
ACL (arrows in Figure 3.12E).   
 
Figure 3.12 H&E staining of cross-sections of BLB explants after six months of 
implantation in vivo as an ACL replacement (A, B, C and D) and of native adult ACL (E). 
The center of section (A and B) made from frozen BMSCs contained viable cells and was 
highly vascularized but did not have well formed collagen fascicles. The cross section (C) 
made from fresh cells suggests possible collagen fascicle formation.  Explant (D) made 
from fresh cells also appeared to have fully remodeled with collagen fascicle size and 
structure that very closely resembled that seen in adult native ACL in (E). 
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We analyzed frozen sections of the middle portion of the BLB explants for 
the presence of both blood vessels and nerves, using anti-CD31 and anti-NCAM 
antibody immunostaining, respectively (Figure 3.13). CD31 (PECAM1) is a 
member of the immunoglobulin superfamily. It is a major constituent of the 
endothelial cell intercellular junctions and is considered to be a specific marker 
for blood vessels. NCAM (neural cell adhesion molecule) is expressed in all 
neurons from very early in the development. It is considered to be a specific 
marker for the neuronal cell bodies, axons and dendrites. We found, after 
following a three-month recovery, the midsection of the BLB-replaced ACL 
contained an extensive vasculature (Figure 3.13B). The vasculature was greater 
than that observed in adult tissues and equivalent to that of a 14-day-old native 
neonatal sheep ACL (Figure 3.14E). Additionally, we observed innervation of 
nerve in the midsection of the replaced ACL (Figure 3.13C, F, and I). After a four-
month recovery, the midsection of the replaced ACL had larger and more 
organized blood vessels and nerves (Figure 3.13E and F) and continued further 
organization of blood vessels and nerves was seen following a six-month 
recovery (Figure 3.13H and I). H&E staining of these same explants showed 
more organized collagen fibers with time in vivo (Figure 3.13A, D, and G).  
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Figure 3.13 Longitudinal sections of BLB explants after (A-C) three, (D-F) four, and (G-I) six 
months of implantation in vivo as an ACL replacement. (A, D & G) H&E staining for 
visualization of general structure and collagen fibers; (B, E & H) CD31 immunostaining for 
visualization of blood vessels; (C, F & I) NCAM immunostaining for visualization of nerves. 
 
Figure 3.14 Longitudinal sections of neonatal and adult native sheep ACL. Pictures of (A-
C) one day old, (D-F) 14 day old and (G-I) adult sheep ACL are shown. (A, D & G) H&E 
staining for visualization of general structure and collagen fibers; (B, E & H) CD31 
immunostaining for visualization of blood vessels; (C, F & I) S-100 immunostaining for 
visualization of nerves. 
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These data suggest that our tissue engineered BLBs remodeled in vivo 
with respect to mechanical structure (collagen alignment) and biological function 
as indicated by the vascularization and innervation. To compare the explants with 
native sheep ligaments, we stained frozen longitudinal tissue sections from one-
day, 14-day and adult sheep ACL for general structure, vascularization and 
innervation (Figure 3.14). The innervation and vascularization of the BLB 
explants at six months (Figure 3.13H and I) in vivo resembles that of the adult 
ACL (Figure 3.14H and I). 
 
3.3.4.3 Analysis of BLB/native bone interface 
Figure 3.15 shows a demineralized longitudinal section of a BLB explant 
after two months in vivo as an ACL replacement. Within two months as an ACL 
replacement in the sheep, our BLB constructs integrated well with native tissue to 
form a structurally viable and biochemically relevant enthesis. Sharpey’s fibers 
(white arrow in Figure 3.15A) indicate integration of native bone with the 
engineered tissue. Aligned nuclei (white arrow) indicative of a fibrocartilagenous 
region are seen in Figure 3.15B. 
 
Figure 3.15 BLB explant / native bone interface two months after implantation in vivo as an 
ACL replacement. Two sections of the BLB explant shows (A) integration into native bone 
through the Sharpey’s fibers (arrow) and (B) fibrocartilaginous region with aligned nuclei 
(arrow). 
3.3.4.4 Analysis of structure, vascularization, innervation and elastin of the 
native ACL, the BLB and the PTG at 9-month 
The H&E stained cross sections through the center of the BLB explant 
after 9 months in vivo showed viable cells (Figure 3.16). Some BLBs (N=2; 
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Figure 3.16A) had remodeled areas with collagen fascicle size and structure that 
very closely resembled that seen in adult native ACLs (Figure 3.16B).  
 
Figure 3.16 H&E staining of cross-sections of BLB explants after 9 months in vivo as an 
ACL replacement (A) and of native adult ACL (B). The center of section (A) appeared to 
have fully remodeled with collagen fascicle size and structure that very closely resembled 
that seen in adult native ACL in (B). 
Two additional BLBs that were analyzed did not have well developed 
collagen fascicles. The BLBs were also highly vascularized suggesting that they 
were fully viable and actively remodeling and growing (Figure 3.17E). The overall 
structure of the extracellular matrix (WGA, collagen type I and elastin staining), 
vascularization (CD31) and innervation (NCAM) of the BLB explants (N=4; Figure 
3.17D-F) resembled those of the native ACLs (Figure 3.17 A-C).  Collagen in 
PTGs was less organized than in the ACLs and BLBs (Figure 3.17G). More oval 
shaped tenocytes were found in these PTGs (Figure 3.17G) as well as in native 
PT (not shown) whereas the cells in ACLs (Figure 3.17A) or BLBs (Figure 3.17D) 
tended to be more elongated. Some of the PTGs also showed evidence of 
vascularization and innervation (N=2; Figure 3.17H, I). However, vascularization 
and innervation were poor in some PTGs (N=2). Elastin was found in PTGs 
(Figure 3.18B) but to a far lesser extent than in BLBs (Figure 3.18A). 
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Figure 3.17 Longitudinal sections of native ACL (A-C), BLB explants (D-F) and PTG (G-I) 
after 9 months in vivo as an ACL replacement. (A, D & G) H&E staining for visualization of 
general structure and collagen fibers; (B, E & H) CD31 immunostaining for visualization of 
blood vessels; (C, F & I) NCAM immunostaining for visualization of nerves. All images 
have the same scale bar. Scale bar = 0.05mm. 
 
Figure 3.18 Longitudinal sections of BLB (A) and PTG (B) after 9 months in vivo as an ACL 
replacement immunostaining for elastin. All images have the same scale bar. Scale bar = 
0.05mm. 
 
3.3.4.5 Analysis of Lubricin of the ACL, the BLB Explant and the PTG 
The cross sections through the center of the ACL not only showed intense 
lubricin immunostaining along the surface of the ACL but the cells inside the ACL 
were found to express lubricin (Figure 3.19A). The cross sections of BLBs also 
showed lubricin inside the BLBs (Figure 3.19B). PTGs showed very weak 
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staining for lubricin in the center (Figure 3.19C). The BLB cross (Figure 3.19B) 
and longitudinal sections demonstrated lubricin staining (Figure 3.19E) 
resembling that of native ACLs (Figure 3.19A and D). 
 
Figure 3.19 Cross-sectional sections of ACL (A), BLB (B) and PTG (C) after 9 months in 
vivo, and longitudinal sections of ACL (D) and BLB (B) immunostaining for lubricin. All 
images have the same scale bar. Scale bar = 0.05mm 
 
3.3.5 Y chromosome PCR analysis for BLB explant 
Genomic DNA was isolated from tissue samples by proteinase K digestion 
followed by ethanol precipitation. A PCR based assay for the ovine-specific Y-
chromosome repeat sequence Ucd043 was used to determine the presence of 
male cells in BLB explant samples [68]. Duplex PCR was performed using 
SCUcd043.FWD/SCUcd043. REV primers to amplify Ucd043 together with P1-
5EZ/P2-3EZ primers to amplify the ZFY/ZFX locus. P1-5EZ and P2-3EZ primers 
also provided an internal control for amplification. Sensitivity of the assay was 
assessed with a dilution panel of 100, 25 and 5 pg of male ovine DNA. 
Subsequent experimental reactions were carried out with 25 ng of genomic DNA 
template. 
 
In the PCR assay sensitivity tests, dilutions containing as little as 5 pg of 
male DNA were reliably detected (Figure 3.20A).  However, we were unable to 
detect the presence of Y-chromosome from tibial, middle or femoral regions of 
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BLB explants using up to 25 ng of genomic DNA template (N=4; Figure 3.20B).  
The ZFY/ZFX internal PCR control amplified efficiently for all samples and large 
amounts of female DNA were present. 
 
Figure 3.20 Y-Chromosome PCR assay sensitivity test (A) showed the Y-chromosome 
locus Ucd043 (upper band) was reliably detected from dilutions of 100, 25 and 5 pg of male 
ovine DNA.  The lower band corresponds to the ZFY/ZFX locus present on both X- and Y-
chromosomes and acts as an internal PCR control. Y-Chromosome is undetectable in BLB 
Explants by PCR Analysis (B). Lanes 1-3, genomic DNA from BLB explants; lane 4, no 
template; lane 5, genomic DNA from female sheep; lane 6, genomic DNA from male sheep; 
lane 7, no template; lane 8, 1 Kb Plus DNA Ladder (Invitrogen). Reactions contained 25 ng 
of template DNA.  Upper band corresponds to Ucd043 PCR product which is specific to the 
Y-Chromosome and lower band corresponds to the ZFY/ZFX positive control.   
 
3.3.6 Summary 
The resulting 3D multi-phasic bone-ligament-bone (BLB) constructs exhibit 
the structural and functional interface characteristics of native rat MCL and sheep 
ACL by utilizing engineered ligament with engineered bone at each end. We 
hypothesize that the BLB constructs can integrate into the recipient bone to form 
a mechanically viable and biochemically relevant interface between the two 
tissues and allow rapid growth of the BLB construct to attain histological 
properties that resemble those of native, adult ACL [67]. The ingrowth of blood 
vessel and nerve demonstrates the incorporation of our tissue engineered BLB 
graft in the host. The complete replacement of the cell population in our 9-month 
comparison study (3.3.5) further demonstrates its successful integration and is 
consistent with previous goat ACL research [69]. The superficial and deep 
presence of lubricin in the BLB is exciting, knowing the importance that this 
protein plays in normal joint function [70, 71]. The elastin pattern of the BLB is 
similar to that of the contra-lateral ACL (data not shown); more so than that of the 
PTG. Elastin is not seen in the BLB in vitro and represents “ligamentization” of 
the engineered construct. 





















































In our rat MCL replacement study, we demonstrate that the engineered 
BLB construct has great potential for use as a ligament due to its ability to 
generate the extracellular matrix that resembles that of he native rat MCL after 
either one or two months in vivo recovery. In the sheep ACL replacement 
studies, we demonstrate that the engineered BLB has tremendous potential as 
an ACL replacement as well as an MCL replacement, despite the inhospitable 
environment of the intra-articular region.  The success of our BLB graft as an 
ACL replacement in our large animal model suggests this approach may have 
clinical relevance in ACL replacement in humans. 
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